Journal articles on the topic 'Pang huang (Lu, Xun)'

Abstract Antibody-drug conjugates (ADCs) such as HER2 ADC Enhertu and TROP2 ADC Trodelvy have been proved to be the promising therapeutic agents in portion of cancer diseases. However, there are still numerous patients refractory to the therapy, indicating that the efficacy of ADCs may need to be further optimized. Here, we report that the excessive cancer-associated fibroblasts (CAFs) can serve as a fibrotic barrier, to the detriment of anti-tumor effects from ADCs by alleviating their tissue penetration. Mechanistically, the cancer cells can transform the normal fibrotic cells into CAFs which are featured by the hyperactivated focal adhesion kinase (FAK) signaling. The fast-growing CAFs would decrease the tumor uptake of the big molecules, conferring drug resistance of ADCs to the cancer cells. Targeting FAK with a small molecule inhibitor IN10018 is capable to reduce CAFs associated tumor barrier, elevating the tissue penetration of different types of ADCs regardless their respective targets. The combination regimen comprising IN10018 and the ADCs targeting either HER2 or TROP2 outperformed each monotherapy with respect to antitumor outcomes in different animal experiments. The preclinical evidence for the dual regimen of IN10018 and ADCs warrants a further validation in clinical settings. Citation Format: Baoyuan Zhang, Zhixiang Zhang, Jiaming Gao, Shiqiang Lu, Ran Pang, Dongfang Li, Xun Huang, Natasha Qin, Leo Liu, Zaiqi Wang. Targeting FAK improves the tumor penetration of antibody-drug conjugates to strengthen the anti-cancer responses [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 4655.

Abstract. City is a symbol of modernity. The revival of the Urban Fiction genre in contemporary Chinese literature is driven by writers of the 1970s. It portrays not only urban landscapes with the beauty in their works, but also exposes the souls that suffer in urban spaces. As a symbol of a modern, advanced and civilized life portrayed in Huang Yongmei's short story "Rearview Mirror", it has a dark side. Various changes that move to bring progress do not necessarily change the fate and fortune of urban people who live in it. Instead of being able to enjoy a comfortable and orderly urban space, an elderly former truck driver in the text seems to be moving back in time. Huang Yongmei, literary winner of the 7th Lu Xun literary award (2018), builds allegories about denial of the progress or modernity of today's China. The Rearview Mirror property serves as a kind of reminder of how many parts of past lives have been left behind as we go fast in the flow of change. The magnitude of the progress and the change can only be measured by constantly looking back to its rickety and worn-out past. The suffer of the city people in old age is symbolized with the scene of going backwards, as a healing therapy for the abnormal spine due to sitting behind the wheel for too long. When the city people rush over each day, this old man goes backwards. The complexity of big city problems make the elderly desperate. Widower in old age, deceived by false loyalty, habit of going back to the past have turned into a swimming backstroke. Huang Yongmei has arrived to the point of firmness by keeping the urban’s subject away from the sparkling city life that just makes the little people suffer. The Father's Rearview Mirror text asserts that the urban subject who suffers in his last days leave his hometown, for good.

Abstract Background: Chimeric antigen receptor (CAR) T-cell therapy has shown remarkable clinical efficacy in hematologic malignancies but limited success in solid tumors. GCC19CART, the first clinical candidate from the CoupledCAR solid tumor platform, is designed to overcome the limitations of conventional CAR T-cells in solid tumor malignancies by pairing solid tumor CAR T-cells with CD19 targeting CAR T-cells to amplify proliferation and activation of the solid tumor CAR T component. GCC19CART targets guanylate cyclase-C (GCC) which is expressed in the metastatic lesions of 70%-80% of subjects with colorectal cancers. A Phase 1 investigator-initiated clinical trial is underway in China for patients with relapsed or refractory metastatic colorectal cancer who have received at least 2 prior lines of therapy. Based on a data cutoff on October 20, 2022 21 subjects have been enrolled in 2 dose escalation groups at 5 hospitals in China. Methods: Subjects are screened for GCC expression by immunohistochemistry. Eligible subjects undergo leukapheresis, a single dose of lymphodepleting chemotherapy (fludarabine 30mg/m2 and cyclophosphamide 300mg/m2) 3 days prior to infusion, and then administration of a single infusion of GCC19CART at one of two preassigned doses: 1 × 106 or 2 × 106 CAR T-cells/kg. Endpoints are safety and preliminary evidence of efficacy as determined by CT or PET/CT per RECIST 1.1 or PERCIST 1.0. All responses were confirmed by an independent third-party imaging contract research organization (CRO). Results: 13 subjects have been enrolled to dose level 1 (1 × 106 cells/kg) and 8 subjects have been enrolled to dose level 2 (2 × 106 cells/kg). The most common adverse events were cytokine release syndrome (CRS) in 21/21 subjects (Grade 1 19/21 (90.48%) or Grade 2 2/21 (9.52%)) and diarrhea in 21/21 subjects (Grade 1 6/21 (28.57%) Grade 2 5/21 (23.81%) Grade 3 9/21 (42.86%) or Grade 4 1/21 (4.76%)). Neurotoxicity was observed in 2/21 (9.52%) subjects at Grade 3 or 4 and resolved with corticosteroids. The combined overall response rate (ORR) for both dose levels was 28.6% (6/21). For dose level 1, the overall response rate (ORR) per RECIST 1.1 was 15.4% (2/13). Two subjects demonstrated a partial response (PR) while 3 additional subjects had partial metabolic response (PMR) on PET/CT with stable disease (SD) or progressive disease (PD) per RECIST 1.1. For dose level 2, The ORR per RECIST 1.1 was 50% (4/8). 4 subjects demonstrated a PR (3 at month 1, 1 at month 3 after being SD at month 1) and 2 additional subjects had PMR on PET/CT with SD per RECIST 1.1. Conclusions: preliminary data show that GCC19CART has meaningful dose dependent clinical activity and an acceptable safety profile in relapsed or refractory metastatic colorectal cancer. This trial is ongoing and updated data will be presented. A Phase 1 trial of GCC19CART in the US under a cleared IND is expected to enroll patients from mid-2022. Citation Format: Naifei Chen, Chengfei Pu, Lingling Zhao, Ning Li, Chang Wang, Yusheng Huang, Suxia Luo, Xun Li, Zhenzhou Yang, Jun Bie, Ruihong Zhu, Xi Huang, Haiyang Tang, Tingting Liang, Yizhuo Wang, Beibei Jia, Dongqi Chen, Zhao Wu, Yongping Song, Victor Lu, Lei Xiao, Jiuwei Cui. A phase 1 dose escalation study of GCC19CART - a novel CoupledCAR therapy for subjects with metastatic colorectal cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 1130.

BackgroundRecent data suggested an association between Tofacitinib treatment and increased cardiovascular events in patients with Rheumatoid arthritis. Janus Kinase inhibitors (JAKi), specifically JAK3, have been demonstrated to be one of the regulators of platelet function. Treating platelets with thrombin induces tyrosine phosphorylation of the JAK3 target substrates STAT1 and STAT3, and JAK3 deficiency in mice reduces platelet aggregation and improves event-free survival in thromboplastin-induced thromboembolism.ObjectivesThis study aimed to study the ability of the JAK1/JAK3 inhibitor, Tofacitinib, to influence platelet activity in patients with Rheumatoid Arthritis.MethodsWe enrolled patients with a diagnosis of RA according to the ACR/EULAR 2010 ACR/EULAR criteria. Peripheral blood was obtained from RA patients at the baseline and after 1, 3 and 6 months of Tofacitinib therapy.Platelet aggregation assay was performed by optical aggregometry stimulated with the thromboxane A2receptor in RA patients and controls. The aggregation test was performed before starting the therapy with Tofacitinib and after one month, three months and six months.Results25 RA patients treated with Tofacitinib were recruited, 86% female and 14 % male, with a mean age of 56.5 years (SD 9.7 yrs.), mean disease duration of 16.3 years, mean ESR 28.2 mm, mean CRP 0.9 mg/dl, mean SDAI 18.2 and mean prednisone equivalent dose 3.75 mg/die. 78% of the patients were positive for Rheumatoid factor and 57.1% for ACPA. Looking at the classical risk factors, 35.7 had hypertension, 21.4% had hypercholesterolemia, 16.2% had diabetes, and 14.2% were smokers.; only one patient had a previous cardiovascular event.The platelet aggregation was not influenced by Tofacitinib treatment at any time points (T1, T3 and T6) at any Thromboxane dose (5uM and 20 uM), furthermore did not differ from patients and controls basally (64%, SD 15.84% vs 62%, SD 10.5%).ConclusionIn conclusion, Tofacitinib does not increase platelet aggregation in patients treated for Rheumatoid Arthritis.References[1]Lu, W.-J., Lin, K.-C., Huang, S.-Y., Thomas, P. A., Wu, Y.-H., Wu, H.-C., Lin, K.-H., & Sheu, J.-R. (2014). Role of a Janus kinase 2-dependent signaling pathway in platelet activation.Thrombosis Research,133(6), 1088–1096.[2]Parra-Izquierdo, I., Melrose, A. R., Pang, J., Lakshmanan, H. H. S., Reitsma, S. E., Vavilapalli, S. H., Larson, M. K., Shatzel, J. J., McCarty, O. J. T., & Aslan, J. E. (2022). Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function.Platelets,33(3), 404–415.AcknowledgementsResearch was supported by an unrestricted grant by Pfizer.Disclosure of InterestsDaniele Mauro Grant/research support from: Research was supported by an unrestricted grant by Pfizer, Daniela Iacono Grant/research support from: Research was supported by an unrestricted grant by Pfizer, Ilenia Pantano Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Maura Raimondi Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Maria Laura Marchesano Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Flavia Riccio Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Anna Pellegrino Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Vasiliki Liakouli Grant/research support from: Some research was supported by an unrestricted grant by Pfizer, Francesco Ciccia Grant/research support from: Some research was supported by an unrestricted grant by Pfizer.

The work describes the technology of a liquid crystal cell with a tapered optical fiber as an element providing light. The tapered optical fiber with the total optical loss of 0.22 ± 0.07 dB, the taper waist diameter of 15.5 ± 0.5 μm, and the elongation of 20.4 ± 0.3 mm has been used. The experimental results are presented for a liquid crystal cell filled with a mixture 1550* for parallel orientation of LC molecules to the cross section of the taper waist. Measurement results show the influence of the electrical field with voltage in the range of 0-200 V, without, as well as with different modulation for spectral characteristics. The sinusoidal and square signal shapes are used with a 1-10 Hz frequency range. Full Text: PDF ReferencesZ. Liu, H. Y. Tam, L. Htein, M. L.Vincent Tse, C. Lu, "Microstructured Optical Fiber Sensors", J. Lightwave Technol. 35, 16 (2017). CrossRef T. R. Wolinski, K. Szaniawska, S. Ertman1, P. Lesiak, A. W. Domański, R. Dabrowski, E. Nowinowski-Kruszelnicki, J. Wojcik "Influence of temperature and electrical fields on propagation properties of photonic liquid-crystal fibres", Meas. Sci. Technol. 17, 5 (2006). CrossRef K. Nielsen, D. Noordegraaf, T. Sørensen, A. Bjarklev,T. Hansen, "Selective filling of photonic crystal fibres", J. Opt. A: Pure Appl. Opt. 7, 8 (2005). CrossRef A. A. Rifat, G. A. Mahdiraji, D. M. Chow, Y, Gang Shee, R. Ahmed, F. Rafiq, M Adikan, "Photonic Crystal Fiber-Based Surface Plasmon Resonance Sensor with Selective Analyte Channels and Graphene-Silver Deposited Core", Sensors 15, 5 (2015) CrossRef Y. Huang, Z.Tian, L.P. Sun, D. Sun, J.Li, Y.Ran, B.-O. Guan "High-sensitivity DNA biosensor based on optical fiber taper interferometer coated with conjugated polymer tentacle", Opt. Express 23, 21 (2015). CrossRef X. Wang, O. S. Wolfbeis, "The 2016 Annual Review Issue", Anal. Chem., 88, 1 (2016). CrossRef Ye Tian, W. Wang, N. Wu, X. Zou, X.Wang, "Tapered Optical Fiber Sensor for Label-Free Detection of Biomolecules", Sensors 11, 4 (2011). CrossRef O. Katsunari, Fundamentals of Optical Waveguides, (London, Academic Press, (2006). DirectLink A. K. Sharma, J. Rajan, B.D. Gupta, "Fiber-Optic Sensors Based on Surface Plasmon Resonance: A Comprehensive Review", IEEE Sensors Journal 7, 8 (2007). CrossRef C. Caucheteur, T. Guo, J. Albert, "Review of plasmonic fiber optic biochemical sensors: improving the limit of detection", Anal. Bioanal.Chem. 407, 14 (2015). CrossRef S. F. Silva L. Coelho, O. Frazão, J. L. Santos, F. X.r Malcata, "A Review of Palladium-Based Fiber-Optic Sensors for Molecular Hydrogen Detection", IEEE SENSORS JOURNAL 12, 1 (2012). CrossRef H. Waechter, J. Litman, A. H. Cheung, J. A. Barnes, H.P. Loock, "Chemical Sensing Using Fiber Cavity Ring-Down Spectroscopy", Sensors 10, 3 (2010). CrossRef S. Zhu, F. Pang, S. Huang, F.Zou, Y.Dong, T.Wang, "High sensitivity refractive index sensor based on adiabatic tapered optical fiber deposited with nanofilm by ALD", Opt. Express 23, 11 (2015). CrossRef L. Zhang, J. Lou, L. Tong, "Micro/nanofiber optical sensors", Photonics sensor 1, 1 (2011). CrossRef L.Tong, J. Lou, E. Mazur, "Single-mode guiding properties of subwavelength-diameter silica and silicon wire waveguides", Opt. Express 11, 6 (2004). CrossRef H. Moyyed, I. T. Leite, L. Coelho, J. L. Santos, D. Viegas, "Analysis of phase interrogated SPR fiber optic sensors with bimetallic layers", IEEE Sensors Journal 14, 10 (2014). CrossRef A. González-Cano, M. Cruz Navarette, Ó. Esteban, N. Diaz Herrera , "Plasmonic sensors based on doubly-deposited tapered optical fibers", Sensors 14, 3 (2014). CrossRef K. A. Stasiewicz, J.E. Moś, "Threshold temperature optical fibre sensors", Opt. Fiber Technol. 32, (2016). CrossRef L. Zhang, F. Gu, J. Lou, X. Yin, L. Tong, "Fast detection of humidity with a subwavelength-diameter fiber taper coated with gelatin film", Opt. Express 16, 17 (2008). CrossRef S.Zhu, F.Pang, S. Huang, F. Zou, Q. Guo, J. Wen, T. Wang, "High Sensitivity Refractometer Based on TiO2-Coated Adiabatic Tapered Optical Fiber via ALD Technology", Sensors 16, 8 (2016). CrossRef G.Brambilla, "Optical fibre nanowires and microwires: a review", J. Optics 12, 4 (2010) CrossRef M. Ahmad, L.L. Hench, "Effect of taper geometries and launch angle on evanescent wave penetration depth in optical fibers", Biosens. Bioelectron. 20, 7 (2005). CrossRef L.M. Blinov, Electrooptic Effects in Liquid Crystal Materials (New York, Springftianer, 1994). CrossRef L. Scolari, T.T. Alkeskjold, A. Bjarklev, "Tunable Gaussian filter based on tapered liquid crystal photonic bandgap fibre", Electron. Lett. 42, 22 (2006). CrossRef J. Moś, M. Florek, K. Garbat, K.A. Stasiewicz, N. Bennis, L.R. Jaroszewicz, "In-Line Tunable Nematic Liquid Crystal Fiber Optic Device", J. of Lightwave Technol. 36, 4 (2017). CrossRef J. Moś, K A Stasiewicz, K Garbat, P Morawiak, W Piecek, L R Jaroszewicz, "Tapered fiber liquid crystal hybrid broad band device", Phys. Scripta. 93, 12 (2018). CrossRef Ch. Veilleux, J. Lapierre, J. Bures, "Liquid-crystal-clad tapered fibers", Opt. Lett. 11, 11 (1986). CrossRef R. Dąbrowski, K. Garbat, S. Urban, T.R. Woliński, J. Dziaduszek, T. Ogrodnik, A,Siarkowska, "Low-birefringence liquid crystal mixtures for photonic liquid crystal fibres application", Liq. Cryst. 44, (2017). CrossRef S. Lacroix, R. J. Black, Ch. Veilleux, J. Lapierre, "Tapered single-mode fibers: external refractive-index dependence", Appl. Opt., 25, 15 (1986). CrossRef J.F. Henninot, D. Louvergneaux , N.Tabiryan, M. Warenghem, "Controlled Leakage of a Tapered Optical Fiber with Liquid Crystal Cladding", Mol. Cryst.and Liq.Cryst., 282, 1(1996). CrossRef

Abstract Background: Despite a high response rate to cCRT, patients with limited-stage SCLC generally experience recurrence of disease after a few months and survival remains poor. Immunotherapy has shown benefit in many tumor types, including SCLC. In preclinical and clinical studies of solid tumors, co-inhibition of T-cell immunoreceptor with immunoglobulin and immunoreceptor tyrosine-based inhibitor motif domains (TIGIT) and PD-1 enhanced antitumor activity of anti-PD-1. AdvanTIG-204 (NCT04952597) investigated the efficacy and safety of ociperlimab + tislelizumab + cCRT in patients with untreated limited-stage SCLC. Methods: Patients with limited-stage SCLC and no prior systemic therapy were randomized 1:1:1 to Arm A (ociperlimab [900 mg IV Q3W] + tislelizumab [200 mg IV Q3W] + cCRT for 4 cycles, then ociperlimab + tislelizumab), Arm B (tislelizumab + cCRT for 4 cycles, then tislelizumab), or Arm C (cCRT for 4 cycles). Study drugs (Arms A and B) were continued for up to 12 months or until progression, unacceptable toxicity, or withdrawal. Primary endpoint: investigator-assessed PFS per RECIST v1.1. Secondary analyses included additional efficacy and safety endpoints in the ITT population, and efficacy in patient subgroups by PD-L1 and TIGIT expression (both <1% vs ≥1%), using tumor area positivity (PD-L1) and immune cell scoring (TIGIT). No hypothesis testing was predefined (p-value for descriptive purposes only). Descriptive comparisons were conducted for Arm A vs C, B vs C, and A vs B. Results: As of July 26, 2023, 126 patients (median age, 61.5 years) were randomized to Arm A (n=41), Arm B (n=42), or Arm C (n=43). Median follow-up: ~18 months (all arms). There was a trend of improvement in median PFS in Arm A (12.6 months) and Arm B (13.2 months) vs Arm C (9.5 months); HR (95% CI): Arm A vs C, 0.84 (0.46-1.52; p=0.2793); Arm B vs C, 0.80 (0.45-1.44; p=0.2414). ORR was 85.4% (3 CR) in Arm A, 88.1% (4 CR) in Arm B, and 76.7% (1 CR) in Arm C. Median DoR was 10.1 months in Arm A, 11.5 months in Arm B, and 8.2 months in Arm C. Median OS was not reached in any arm. Analyses showed that PD-L1 or TIGIT expression did not correlate with efficacy, however, small subgroup size limits interpretability. All patients experienced ≥1 treatment-related adverse event (TRAE); rates of grade ≥3 TRAEs were 73.2%, 78.6% and, 65.1% in Arms A, B, and C, respectively. The most common TRAEs included anemia (80.5% in Arm A vs 83.3% in Arm B vs 81.4% in Arm C), nausea (80.5% vs 76.2% vs 65.1%), and WBC count decreased (78.0% vs 76.2% vs 62.8%). Rates of TRAEs leading to any treatment discontinuation were 26.8%, 21.4%, and 4.7% in Arms A, B, and C, respectively. One patient in each arm experienced a TRAE leading to death. Conclusion: In patients with untreated limited-stage SCLC, tislelizumab + cCRT yielded a trend of improvement in PFS and ORR vs cCRT; addition of ociperlimab did not show detectable improvement. The overall safety profile of the treatments was tolerable, manageable, and generally consistent with the known risks of ociperlimab, tislelizumab, and cCRT. Citation Format: Youling Gong, Qingsong Pang, Rong Yu, Zhengfei Zhu, Jiangqiong Huang, Yufeng Cheng, Diansheng Zhong, Hongbo Wu, Seung Soo Yoo, Tracy Dobbs, Zinan Bao, Yunxia Zuo, Boxian Wei, Pu Sun, You Lu. AdvanTIG-204: A phase 2, multicenter, randomized, 3-arm, open-label study investigating the preliminary efficacy and safety of ociperlimab (anti-TIGIT) + tislelizumab (anti-PD-1) + concurrent chemoradiotherapy (cCRT) in patients with untreated limited-stage small cell lung cancer (SCLC) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr CT255.

The paper is the first of a series, which aims to present a consistent interpretation of the suprageneric taxa of fossil beetles in the current century and their generic and species composition. Order Coleoptera is considered in composition of the superorder Coleopteroidea Handlirsch, 1903 (= Coleopterida sensu Boudreaux, 1979, nec Pearse, 1936) together with orders Skleroptera and Strepsiptera, and also with the family Umenocoleidae of unclear position. This paper includes the archostematan superfamilies Coleopseoidea and Cupedoidea of the infraorder Cupediformia, i.e., Coleopseidae (one genus and one species), Tshekardocoleidae (12 genera, 15 species), Labradorocoleidae (one genus, one species), Permocupedidae (together with Taldycupedinae, stat. nov., 24 genera and 54 species) and Cupedidae (three subfamilies, 49 genera, 253 species). The preliminary information on structure of the larva of Tshekardocoleidae from Tshekarda is done. There are also described the new taxa: genus Afrotaldycupes Kirejtshuk, gen. nov. with the type species: genus Taldycupes africanus Ponomarenko in Ponomarenko & Mostovski, 2005 [Afrotaldycupes africanus comb. nov.] and Afrotaldycupes lidgettoniensis (Ponomarenko in Ponomarenko & Mostovski, 2005), comb. nov. [Taldycupes]; genus Allophalerus Kirejtshuk, gen. nov. with the type species: Tetraphalerus aphaleratus Ponomarenko, 1969 [Allophalerus aphaleratus comb. nov.], and also with Allophalerus antiquus (Ponomarenko, 1964), comb. nov. [Tetraphalerus], Allophalerus bontsaganensis (Ponomarenko, 1997), comb. nov. [Tetraphalerus], Allophalerus incertus (Ponomarenko, 1969), comb. nov. [Tetraphalerus], Allophalerus latus (Tan, Ren et Shih, 2007), comb. nov. [Tetraphalerus], Allophalerus maximus (Ponomarenko, 1968), comb. nov. [Tetraphalerus], Allophalerus okhotensis (Ponomarenko, 1993), comb. nov. [Tetraphalerus], Allophalerus tenuipes (Ponomarenko, 1964), comb. nov. [Tetraphalerus], Allophalerus verrucosus (Ponomarenko, 1966), comb. nov. [Tetraphalerus]; genus Bukhkalius Kirejtshuk et Jarzembowski, gen. nov. with the type species: Tetraphalerus lindae Jarzembowski, Wang et Zheng, 2017 [Bukhkalius lindae comb. nov.]; genus Burmocoleus Kirejtshuk, gen. nov. with the type species: Burmocoleus prisnyi sp. nov. and Burmocoleus zhiyuani (Liu, Tan, Ślipiński, Jarzembowski, Wang, Ren et Pang, 2017), comb. nov. [Brochocoleus]; genus Cionocups Kirejtshuk, gen. nov. with the type species: Cionocups manukyani sp. nov.; genus Echinocups Kirejtshuk et Jarzembowski, gen. nov. with the type species: Notocupes neli Tihelka, Huang et Cai, 2020 [Echinocups neli comb. nov.], and also Echinocups ohmkuhnlei (Jarzembowski, Wang et Zheng, 2020), comb. nov. [Notocupes] and Echinocups denticollis (Jiang, Li, Song, Shi, Liu, Chen et Kong, 2020), comb. nov. [Notocupes]; genus Jarzembowskops Kirejtshuk, gen. nov. with the type species: Brochocoleus caseyi Jarzembowski, Wang et Zheng, 2016 [Jarzembowskops caseyi comb. nov.]; genus Lobanovia Kirejtshuk, gen. nov. with the type species: Simmondsia permiana Ponomarenko, 2013 [Lobanovia permiana comb. nov.]; genus Pintolla Kirejtshuk, gen. nov. with the type species: Kaltanicupes ponomarenkoi Pinto, 1987 [Pintolla ponomarenkoi comb. nov.]; genus Polyakius Kirejtshuk, gen. nov. with the type species: Polyakius alberti Kirejtshuk, sp. nov. and Polyakius pubescens Kirejtshuk, sp. nov.; Clessidromma zengi Kirejtshuk, sp. nov.; Cupes golovatchi Kirejtshuk, sp. nov.; Cupes legalovi Kirejtshuk, sp. nov.; Cupes lutzi Kirejtshuk, sp. nov.; Cupes nabozhenkoi Kirejtshuk, sp. nov.; Cupes wedmannae Kirejtshuk, sp. nov.; Mallecupes prokini Kirejtshuk, sp. nov. and Omma janetae Kirejtshuk, sp. nov. The new synonymy is established for the generic names Clessidromma Jarzembowski, Wang et Zheng, 2017 and Lepidomma Jarzembowski, Wang et Zheng, 2019, syn. nov. The rank of Cainomerga A. Kirejtshuk, Nel et P. Kirejtshuk, 2016 is elevated from subgeneric to generic. Also other new combinations are proposed: Cainomerga brevicornis (A. Kirejtshuk, Nel et P. Kirejtshuk, 2016), comb. nov. [Mesocupes], Cainomerga fraterna (A. Kirejtshuk, Nel et P. Kirejtshuk, 2016), comb. nov. [Mesocupes], Cainomerga immaculata (Piton, 1940: 194), comb. nov. [Zonabris, Mesocupes], Cainomerga palaeocenica (A. Kirejtshuk, Nel et P. Kirejtshuk, 2016), comb. nov. [Mesocupes], and Cainomerga ponti (A. Kirejtshuk, Nel et P. Kirejtshuk, 2016), comb. nov. [Mesocupes], Clessidromma tianae (Jarzembowski, Wang et Zheng, 2019), comb. nov. [Lepidomma], Diluticupes applanatus (Tan et Ren, 2009), comb. nov. [Brochocoleus], Diluticupes crowsonae (Jarzembowski, Yan, Wang et Zhang. 2013), comb. nov. [Brochocoleus], Diluticupes magnus (Tan et Ren, 2009), comb. nov. [Brochocoleus], Diluticupes minor (Ponomarenko, 2000), comb. nov. [Brochocoleus], Diluticupes validus (Tan et Ren, 2009), comb. nov. [Brochocoleus], Diluticupes yangshuwanziensis (Jarzembowski, Yan, Wang et Zhang. 2013), comb. nov. [Brochocoleus], Monticupes curtinervis (Tan, Ren et Shih, 2007), comb. nov. [Tetraphalerus], Monticupes decorosus (Tan, Wang, Ren et Yang, 2012), comb. nov. [Tetraphalerus], Odontomma sulcatum (Tan, Ren et Shih, 2007), comb. nov. [Brochocoleus], Omma ancistrodontum (Tan, Wang, Ren et Yang, 2012), comb. nov. [Pareuryomma], Omma grande (Ponomarenko, 1964), comb. nov. [Tetraphalerus], Omma longicolle (Ponomarenko, 1997), comb. nov. [Tetraphalerus], Pareuryomma angustum (Tan, Ren et Shich, 2007), comb. nov. [Brochocoleus], Pareuryomma magnum (Tan et Ren, 2009), comb. nov. [Brochocoleus], Zygadenia aliena (Tan et Ren, 2006), comb. nov. [Ovatocupes], Zygadenia baojiatunensis (Hong 1992), comb. nov. [Chengdecupes], Zygadenia brachycephala (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia caduca (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia caudata (Ponomarenko, 1966), comb. nov. [Notocupes], Zygadenia cellulosa (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia crassa (Ponomarenko, 1969), comb. nov., [Notocupes], Zygadenia cyclodontus (Tan, Ren, Shih et Ge, 2006), comb. nov. [Amblomma, Notocupes], Zygadenia dischdes (Zhang, 1986), comb. nov. [Notocupes], Notocupes dundulaensis (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia elegans (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia epicharis (Tan, Ren et Liu, 2005), comb. nov. [Amblomma, Notocupes], Zygadenia eumeura (Tan, Ren et Liu, 2005), comb. nov. [Amblomma, Notocupes], Zygadenia excellens (Ponomarenko, 1966), comb. nov. [Notocupes], Zygadenia exigua (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia foersteri (Ponomarenko, 1971), comb. nov. [Procarabus, Notocupes], Zygadenia homora (Lin, 1986), comb. nov. [Conexicoxa, Notocupes], Zygadenia issykkulensis (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia jurassica (Hong 1983), comb. nov. [Chengdecupes], Zygadenia kezuoensis (Hong 1987), comb. nov. [Chengdecupes], Zygadenia khasurtuiensis (Strelnikova, 2019), comb. nov. [Notocupes], Zygadenia khetanensis (Ponomarenko, 1993), comb. nov. [Notocupes], Zygadenia kirghizica (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia laeta (Lin, 1976), [Tetraphalerus], Zygadenia laiyangensis (Hong et Wang, 1990), comb. nov. [Forticupes, Notocupes], Zygadenia lapidaria (Ponomarenko, 1968), comb. nov. [Notocupes], Zygadenia laticella (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia lata (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia lenta (Ren, Lu, Guo et Ji, 1995), comb. nov. [Tetraphalerus], Zygadenia lini (Ponomarenko, Yan, Wang et Zhang, 2012), comb. nov. [Notocupes], Zygadenia longicollis (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia ludongensis (Wang et Liu, 1996), comb. nov. [Notocupes], Zygadenia minuscula (Tan, Ren, Shih et Ge, 2006), comb. nov. [Amblomma, Notocupes], Zygadenia mongolica (Ponomarenko, 1994), comb. nov. [Notocupes], Zygadenia nigrimonticola (Ponomarenko, 1968), comb. nov. [Notocupes], Zygadenia oxypyga (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia patula (Ponomarenko, 1985), comb. nov. [Notocupes], Zygadenia pingi (Ponomarenko et Ren, 2010), comb. nov. [Notocupes], Zygadenia porrecta (Tan, Ren, Shih et Ge, 2006), comb. nov. [Amblomma, Notocupes], Zygadenia protensa (Tan, Ren, Shih et Ge, 2006), comb. nov. [Amblomma, Notocupes], Zygodenia psilata (Tan, Ren et Liu, 2005), comb. nov. [Amblomma, Notocupes], , Zygadenia pulchra Ponomarenko, 1968, comb. nov. [Notocupes], Zygadenia reticulata (Oppenheim, 1888), comb. nov. [Procarabus, Notocupes], Notocupes rostrata (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia rudis (Tan, Ren et Liu, 2005), comb. nov. [Amblomma, Notocupes], Zygadenia shiluoensis (Hong 1984), comb. nov. [Chengdecupes], Zygadenia sogutensis (Ponomarenko, 1969), comb. nov., Zygadenia stabilis (Tan, Ren et Liu, 2005), comb. nov. [Amblomma, Notocupes], Zygadenia tenuis (Ponomarenko, 1969), comb. nov. [Notocupes], Zygadenia tripartita (Oppenheim, 1888), comb. nov. [Procarabus, Notocupes], Zygadenia tuanwangensis (Hong et Wang, 1990), comb. nov. [Picticupes, Notocupes], Zygadenia valida (Lin, 1976), comb. nov. [Sinocupes, Notocupes], Zygadenia vitimensis (Ponomarenko, 1966), comb. nov. [Notocupes].

The pandemic of COVID-19 has afflicted every individual and has initiated a cascade of directly or indirectly involved events in precipitating mental health issues. The human species is a wanderer and hunter-gatherer by nature, and physical social distancing and nationwide lockdown have confined an individual to physical isolation. The present review article was conceived to address psychosocial and other issues and their aetiology related to the current pandemic of COVID-19. The elderly age group has most suffered the wrath of SARS-CoV-2, and social isolation as a preventive measure may further induce mental health issues. Animal model studies have demonstrated an inappropriate interacting endogenous neurotransmitter milieu of dopamine, serotonin, glutamate, and opioids, induced by social isolation that could probably lead to observable phenomena of deviant psychosocial behavior. Conflicting and manipulated information related to COVID-19 on social media has also been recognized as a global threat. Psychological stress during the current pandemic in frontline health care workers, migrant workers, children, and adolescents is also a serious concern. Mental health issues in the current situation could also be induced by being quarantined, uncertainty in business, jobs, economy, hampered academic activities, increased screen time on social media, and domestic violence incidences. The gravity of mental health issues associated with the pandemic of COVID-19 should be identified at the earliest. Mental health organization dedicated to current and future pandemics should be established along with Government policies addressing psychological issues to prevent and treat mental health issues need to be developed. References World Health Organization (WHO) Coronavirus Disease (COVID-19) Dashboard. Available at: https://covid19.who.int/ [Accessed on 23 August 2020] Sim K, Chua HC. The psychological impact of SARS: a matter of heart and mind. CMAJ. 2004; 170:811e2. https://doi.org/10.1503/cmaj.1032003. Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, et al. The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk. Can J Psychiatr. 2009; 54:302e11. https://doi.org/10.1177/070674370905400504. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395:912e20. https://doi.org/10.1016/S0140-6736(20)30460-8. Robertson E, Hershenfield K, Grace SL, Stewart DE. The psychosocial effects of being quarantined following exposure to SARS: a qualitative study of Toronto health care workers. Can J Psychiatr. 2004; 49:403e7. https://doi.org/10.1177/070674370404900612. Barbisch D, Koenig KL, Shih FY. Is there a case for quarantine? Perspectives from SARS to Ebola. Disaster Med Public Health Prep. 2015; 9:547e53. https://doi.org/10.1017/dmp.2015.38. Jeong H, Yim HW, Song YJ, Ki M, Min JA, Cho J, et al. Mental health status of people isolated due to Middle East Respiratory Syndrome. Epidemiol Health. 2016;38: e2016048. https://doi.org/10.4178/epih.e2016048. Liu X, Kakade M, Fuller CJ, Fan B, Fang Y, Kong J, et al. Depression after exposure to stressful events: lessons learned from the severe acute respiratory syndrome epidemic. Compr Psychiatr. 2012; 53:15e23. https://doi.org/10.1016/j.comppsych.2011.02.003 Chadda RK, Deb KS. Indian family systems, collectivistic society and psychotherapy. Indian J Psychiatry. 2013;55: S299‑ https://dx.doi.org/10.4103%2F0019-5545.105555. Grover S, Sahoo S, Mehra A, Avasthi A, Tripathi A, Subramanyan A, et al. Psychological impact of COVID‑19 lockdown: An online survey from India. Indian J Psychiatry. 2020; 62:354-62. https://doi.org/ 10.4103/psychiatry.IndianJPsychiatry _427_20. Hawkley LC, Cacioppo JT. Loneliness matters: a theoretical and empirical review of consequences and mechanisms. Ann Behav Med. 2010; 40: 218–27. https://dx.doi.org/10.1007%2Fs12160-010-9210-8. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S0140-6736(20)30211-7. Bhandari S, Sharma R, Singh Shaktawat A, Banerjee S, Patel B, Tak A, et al. COVID-19 related mortality profile at a tertiary care centre: a descriptive study. Scr Med. 2020;51(2):69-73. https://doi.org/10.5937/scriptamed51-27126. Baumeister RF, Leary MR. The need to belong: desire for interpersonal attachments as a fundamental human motivation. Psychol Bull. 1995; 117: 497–529. https://doi.org/10.1037/0033-2909.117.3.497. Caspi A, Harrington H, Moffitt TE, Milne BJ, Poulton R. Socially isolated children 20 years later: risk of cardiovascular disease. Arch Pediatr Adolesc Med. 2006; 160(8):805-11. https://doi.org/10.1001/archpedi.160.8.805. Eaker ED, Pinsky J, Castelli WP. Myocardial infarction and coronary death among women: psychosocial predictors from a 20-year follow-up of women in the Framingham Study. Am J Epidemiol. 1992; 135(8):854-64. https://doi.org/10.1093/oxfordjournals.aje.a116381. Luo Y, Hawkley LC, Waite LJ, Cacioppo JT. Loneliness, health, and mortality in old age: a national longitudinal study. Soc Sci Med. 2012 Mar; 74(6):907-14. https://dx.doi.org/10.1016%2Fj.socscimed.2011.11.028. Olsen RB, Olsen J, Gunner-Svensson F, Waldstrøm B. Social networks and longevity. A 14-year follow-up study among elderly in Denmark. Soc Sci Med. 1991; 33(10):1189-95. https://doi.org/10.1016/0277-9536(91)90235-5. Patterson AC, Veenstra G. Loneliness and risk of mortality: a longitudinal investigation in Alameda County, California. Soc Sci Med. 2010; 71(1):181-6. https://doi.org/10.1016/j.socscimed.2010.03.024. Savikko N, Routassalo P, Tilvis RS, Strandberg TE, Pitkalla KH. Predictors and subjective causes of loneliness in an aged population. Arch Gerontol Geriatrics. 2005; 41:3;223-33. https://doi.org/10.1016/j.archger.2005.03.002. Health Advisory for Elderly Population of India during COVID19. Available at: https://www.mohfw.gov.in/pdf/AdvisoryforElderlyPopulation.pdf [Accessed on 13 August 2020]. Dicks D, Myers R, Kling A. Uncus and amygdala lesions: effects on social behavior in the free-ranging rhesus monkey. Science. 1969; 165:69–71. https://doi.org/10.1126/science.165.3888.69. Kanai R, Bahrami B, Duchaine B, Janik A, Banissy MJ, Rees G. Brain structure links loneliness to social perception. Curr Biol. 2012; 22(20):1975-9. https://dx.doi.org/10.1016%2Fj.cub.2012.08.045. Bender AR, Daugherty A, Raz N. Vascular risk moderates associations between hippocampal subfield volumes and memory. J Cogn Neurosci. 2013; 25:1851–62. https://doi.org/10.1162/jocn_a_00435. Raz N. Diabetes: brain, mind, insulin–what is normal and do we need to know? Nat Rev Endocrinol. 2011; 7:636–7. https://doi.org/10.1038/nrendo.2011.149. Colcombe SJ, Erickson KI, Naftali R, Andrew GW, Cohen NJ, McAuley E, et al. Aerobic fitness reduces brain tissue loss in aging humans. J Gerontol A Biol Sci Med Sci. 2003; 58:176–80. https://doi.org/10.1093/gerona/58.2.m176. Maass A, Düzel S, Goerke M, Becke A, Sobieray U, Neumann K, et al. Vascular hippocampal plasticity after aerobic exercise in older adults. Mol Psychiatry. 2015; 20, 585–93. https://doi.org/10.1038/mp.2014.114. Wilson RS, Krueger KR, Arnold SE, Schneider JA, Kelly JF, Barnes LL, et al. Loneliness and Risk of Alzheimer Disease. Arch Gen Psychiatry. 2007;64(2):234–240. https://doi.org/10.1001/archpsyc.64.2.234. Kogan JH, Frankland PW, Silva AJ. Long-term memory underlying hippocampus-dependent social recognition in mice. Hippocampus. 2000;10(1):47-56. https://doi.org/10.1002/(sici)1098-1063(2000)10:1%3C47::aid-hipo5%3E3.0.co;2-6. Yorgason JT, España RA, Konstantopoulos JK, Weiner JL, Jones SR. Enduring increases in anxiety-like behavior and rapid nucleus accumbens dopamine signaling in socially isolated rats. Eur J Neurosci. 2013;37(6):1022-31. https://doi.org/10.1111/ejn.12113. Bledsoe AC, Oliver KM, Scholl JL, Forster GL. Anxiety states induced by post-weaning social isolation are mediated by CRF receptors in the dorsal raphe nucleus. Brain Res Bull. 2011;85(3-4):117-22. https://dx.doi.org/10.1016%2Fj.brainresbull.2011.03.003. Lukkes JL, Engelman GH, Zelin NS, Hale MW, Lowry CA. Post-weaning social isolation of female rats, anxiety-related behavior, and serotonergic systems. Brain Res. 2012; 1443:1-17. https://dx.doi.org/10.1016%2Fj.brainres.2012.01.005. Ago Y, Araki R, Tanaka T, Sasaga A, Nishiyama S, Takuma K, et al. Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice. Neuropsychopharmacology. 2013; 38(8):1535-47. https://doi.org/10.1038/npp.2013.52. Veenema AH. Early life stress, the development of aggression and neuroendocrine and neurobiological correlates: what can we learn from animal models? Front Neuroendocrinol. 2009;30(4):497-518. https://doi.org/10.1016/j.yfrne.2009.03.003. Zhao X, Sun L, Jia H, Meng Q, Wu S, Li N, et al. Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(7):1173-1177. https://doi.org/10.1016/j.pnpbp.2009.06.016. Sciolino NR, Bortolato M, Eisenstein SA, Fu J, Oveisi F, Hohmann AG, et al. Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats. Neuroscience. 2010;168(2):371-86. https://dx.doi.org/10.1016%2Fj.neuroscience.2010.04.007. Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neurosci Biobehav Rev. 2014; 47:336-358. https://doi.org/10.1016/j.neubiorev.2014.08.017. Olivenza R, Moro MA, Lizasoain I, Lorenzo P, Fernández AP, Rodrigo J, et al. Chronic stress induces the expression of inducible nitric oxide synthase in rat brain cortex. J Neurochem. 2000;74(2):785-791. https://doi.org/10.1046/j.1471-4159.2000.740785.x. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, et al. Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry. 2008;63(4):349-352. https://doi.org/10.1016/j.biopsych.2007.05.028. Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol. 2008;7(8):742-755. https://dx.doi.org/10.1016%2FS1474-4422(08)70165-0. Waxman EA, Lynch DR. N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease. The Neuroscientist. 2005; 11(1), 37–49. https://doi.org/10.1177/1073858404269012. Hermes G, Li N, Duman C, Duman R. Post-weaning chronic social isolation produces profound behavioral dysregulation with decreases in prefrontal cortex synaptic-associated protein expression in female rats. Physiol Behav. 2011;104(2):354-9. https://dx.doi.org/10.1016%2Fj.physbeh.2010.12.019. Sestito RS, Trindade LB, de Souza RG, Kerbauy LN, Iyomasa MM, Rosa ML. Effect of isolation rearing on the expression of AMPA glutamate receptors in the hippocampal formation. J Psychopharmacol. 2011;25(12):1720-1729. https://doi.org/10.1177/0269881110385595. Toua C, Brand L, Möller M, Emsley RA, Harvey BH. The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats. Neuroscience. 2010;165(2):492-499. https://doi.org/10.1016/j.neuroscience.2009.10.039. Alò R, Avolio E, Mele M, Storino F, Canonaco A, Carelli A et al. Excitatory/inhibitory equilibrium of the central amygdala nucleus gates anti-depressive and anxiolytic states in the hamster. Pharmacol Biochem Behav. 2014; 118:79-86. https://doi.org/10.1016/j.pbb.2014.01.007. St JP, Petkov VV. Changes in 5-HT1 receptors in different brain structures of rats with isolation syndrome. General pharmacology. 1990;21(2):223-5. https://doi.org/10.1016/0306-3623(90)90905-2. Miachon S, Rochet T, Mathian B, Barbagli B, Claustrat B. Long-term isolation of Wistar rats alters brain monoamine turnover, blood corticosterone, and ACTH. Brain Res Bull. 1993;32(6):611-614. https://doi.org/10.1016/0361-9230(93)90162-5. Van den Berg CL, Van Ree JM, Spruijt BM, Kitchen I. Effects of juvenile isolation and morphine treatment on social interactions and opioid receptors in adult rats: behavioural and autoradiographic studies. Eur J Neurosci. 1999;11(9):3023-3032. https://doi.org/10.1046/j.1460-9568.1999.00717.x. Vanderschuren LJ, Stein EA, Wiegant VM, Van Ree JM. Social play alters regional brain opioid receptor binding in juvenile rats. Brain Res. 1995;680(1-2):148-156. https://doi.org/10.1016/0006-8993(95)00256-p. Moles A, Kieffer BL, D'Amato FR. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science. 2004;304(5679):1983-1986. https://doi.org/10.1126/science.1095943. Panksepp J, Herman BH, Vilberg T, Bishop P, DeEskinazi FG. Endogenous opioids and social behavior. Neurosci Biobehav Rev. 1980;4(4):473-487. https://doi.org/10.1016/0149-7634(80)90036-6. Gong JP, Onaivi ES, Ishiguro H, Liu Q, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 2006;1071(1):10-23. https://doi.org/10.1016/j.brainres.2005.11.035. Breivogel CS, Sim-Selley LJ. Basic neuroanatomy and neuropharmacology of cannabinoids. Int Rev Psychiatry 2009; 21:2:113-121. https://doi.org/10.1080/09540260902782760. Haj-Mirzaian A, Amini-Khoei H, Haj-Mirzaian A, Amiri S, Ghesmati M, Zahir M, et al. Activation of cannabinoid receptors elicits antidepressant-like effects in a mouse model of social isolation stress. Brain Res Bull. 2017; 130:200-210. https://doi.org/10.1016/j.brainresbull.2017.01.018. Banach M, Piskorska B, Czuczwar SJ, Borowicz KK. Nitric Oxide, Epileptic Seizures, and Action of Antiepileptic Drugs. CNS & Neurological Disorders - Drug Targets 2011;10: 808. https://doi.org/10.2174/187152711798072347. Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829-37, 837a-837d. https://dx.doi.org/10.1093%2Feurheartj%2Fehr304. Hu Y, Wu D, Luo C, Zhu L, Zhang J, Wu H, et al. Hippocampal nitric oxide contributes to sex difference in affective behaviors. PNAS. 2012, 109 (35) 14224-14229. https://doi.org/10.1073/pnas.1207461109. Khan MI, Ostadhadi S, Zolfaghari S, Mehr SE, Hassanzadeh G, Dehpour, A et al. The involvement of NMDA receptor/NO/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test. Neuroscience Letters. 2016; 612:52-61. https://doi.org/10.1016/j.neulet.2015.12.006. Matsumoto K, Puia G, Dong E, Pinna G. GABAA receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: Possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress. 2007; 10:1:3-12. https://doi.org/10.1080/10253890701200997. Zlatković J, Filipović D. Chronic social isolation induces NF-κB activation and upregulation of iNOS protein expression in rat prefrontal cortex. Neurochem Int. 2013;63(3):172-179. https://doi.org/10.1016/j.neuint.2013.06.002. Haj-Mirzaian A, Amiri S, Kordjazy N, Momeny M, Razmi A, Balaei MR, et al. Lithium attenuated the depressant and anxiogenic effect of juvenile social stress through mitigating the negative impact of interlukin-1β and nitric oxide on hypothalamic-pituitary-adrenal axis function. Neuroscience. 2016; 315:271-285. https://doi.org/10.1016/j.neuroscience.2015.12.024. Larson HJ. The biggest pandemic risk? Viral misinformation. Nature 2018; 562:309. https://doi.org/10.1038/d41586-018-07034-4. Zarocostas J. How to fight an infodemic. Lancet 2020; 395:676. https://doi.org/10.1016/S0140-6736(20)30461-X. World Health Organization, 2019. Ebola Virus Disease – Democratic Republic of the Congo. Geneva, Switzerland: WHO. Available at: https://www.who.int/csr/don/28-november-2019-ebola-drc/en/ [Accessed on August 8, 2020] Times of India. Covid-19: doctors gone to collect samples attacked in Indore. Available at: https://timesofindia.indiatimes.com/videos/news/covid-19-doctors-goneto- collect-samples-attacked-in-indore/videoshow/74942153.cms; 2020 [Accessed on August 8, 2020]. Withnall A. Coronavirus: why India has had to pass new law against attacks on healthcare workers. The Independent. April 23, 2020. Semple K. “Afraid to be a nurse”: health workers under attack. The New York Times. 2020 Apr 27. The Economist. Health workers become unexpected targets during COVID-19. The Economist. May 11, 2020. Turan B, Budhwani H, Fazeli PL, Browning WR, Raper JL, Mugavero MJ, et al. How does stigma affect people living with HIV? The mediating roles of internalized and anticipated HIV stigma in the effects of perceived community stigma on health and psychosocial outcomes. AIDS Behav. 2017; 21: 283–291. https://doi.org/10.1007/s10461-016-1451-5. James PB, Wardle J, Steel A, Adams J. An assessment of Ebola-related stigma and its association with informal healthcare utilisation among Ebola survivors in Sierra Leone: a cross sectional study. BMC Public Health. 2020; 20: 182. https://doi.org/10.1186/s12889-020-8279-7. Aljazeera, 2020. Iran: Over 700 Dead after Drinking Alcohol to Cure Coronavirus. Aljazeera. Available at: https://www.aljazeera.com/ news/2020/04/iran-700-dead-drinking-alcohol-cure-coronavirus200427163529629.html. (Accessed June 4, 2020) Delirrad M, Mohammadi AB, 2020. New methanol poisoning outbreaks in Iran following COVID-19 pandemic. Alcohol Alcohol. 55: 347–348. https://doi.org/10.1093/alcalc/agaa036. Hassanian-Moghaddam H, Zamani N, Kolahi A-A, McDonald R, Hovda KE. Double trouble: methanol outbreak in the wake of the COVID-19 pandemic in Iran-a cross-sectional assessment. Crit Care. 2020; 24: 402. https://doi.org/10.1186/s13054-020-03140-w. Soltaninejad K. Methanol Mass Poisoning Outbreak: A Consequence of COVID-19 Pandemic and Misleading Messages on Social Media. Int J Occup Environ Med. 2020;11(3):148-150. https://dx.doi.org/10.34172%2Fijoem.2020.1983. Islam MS, Sarkar T, Khan SH, Kamal AM, Hasan SMM, Kabir A, et al. COVID-19–Related Infodemic and Its Impact on Public Health: A Global Social Media Analysis. Am J Trop Med Hyg. 2020; 00(0):1–9. https://doi.org/10.4269/ajtmh.20-0812. Hawryluck L, Gold W, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004;10(7):1206–1212. https://dx.doi.org/10.3201%2Feid1007.030703. Lee S, Chan LYY, Chau AAM, Kwok KPS, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Soc Sci Med. 2005; 61(9): 2038-2046. https://doi.org/10.1016/j.socscimed.2005.04.010. Yoon MK Kim SY Ko HS Lee MS. System effectiveness of detection, brief intervention and refer to treatment for the people with post-traumatic emotional distress by MERS: a case report of community-based proactive intervention in South Korea. Int J Ment Health Syst. 2016; 10: 51. https://doi.org/10.1186/s13033-016-0083-5. Reynolds DL, Garay JR, Deamond SL, Moran MK, Gold W, Styra R. Understanding, compliance and psychological impact of the SARS quarantine experience. Epidemiol Infect. 2008; 136: 997-1007. https://dx.doi.org/10.1017%2FS0950268807009156. Marjanovic Z, Greenglass ER, Coffey S. The relevance of psychosocial variables and working conditions in predicting nurses' coping strategies during the SARS crisis: an online questionnaire survey. Int J Nurs Stud. 2007; 44(6): 991-998. https://doi.org/10.1016/j.ijnurstu.2006.02.012. Bai Y, Lin C-C, Lin C-Y, Chen J-Y, Chue C-M, Chou P. Survey of stress reactions among health care workers involved with the SARS outbreak. Psychiatr Serv. 2004; 55: 1055-1057. https://doi.org/10.1176/appi.ps.55.9.1055. Ministry of Health and Family Welfare. Available at: https://www.mohfw.gov.in/pdf/Guidelinesforhomequarantine.pdf [Accessed on 25 August 2020]. Ministry of Health and Family Welfare. Available at: https://www.mohfw.gov.in/pdf/RevisedguidelinesforHomeIsolationofverymildpresymptomaticCOVID19cases10May2020.pdf [Accessed on 25 August 2020]. Ministry of Health and Family Welfare. Available at: https://www.mohfw.gov.in/pdf/AdvisoryformanagingHealthcareworkersworkinginCOVIDandNonCOVIDareasofthehospital.pdf (Accessed on 25 August 2020). Ministry of Health and Family Welfare. Available at: https://www.mohfw.gov.in/pdf/RevisedguidelinesforInternationalArrivals02082020.pdf [Accessed on 25 August 2020]. Cost of the lockdown? Over 10% of GDP loss for 18 states. Available at: https://timesofindia.indiatimes.com/india/cost-of-the-lockdown-over-10-of-gdp-loss-for-18-states/articleshow/76028826.cms [Accessed on 21 August 2020]. Jorda O, Singh SR, Taylor AM. Longer-Run Economic Consequences of Pandemics. Federal Reserve Bank of San Francisco Working Paper. 2020-09. https://doi.org/10.24148/wp2020-09. Firdaus G. Mental well‑being of migrants in urban center of India: Analyzing the role of social environment. Indian J Psychiatry. 2017; 59:164‑ https://doi.org/10.4103/psychiatry.indianjpsychiatry_272_15. National Crime Record Bureau. Annual Crime in India Report. New Delhi, India: Ministry of Home Affairs; 2018. 198 migrant workers killed in road accidents during lockdown: Report. Available at: https://www.hindustantimes.com/india-news/198-migrant-workers-killed-in-road-accidents-during-lockdown-report/story-hTWzAWMYn0kyycKw1dyKqL.html [Accessed on 25 August 2020]. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. Lancet Infect Dis. 2020; 20:689-96. https://doi.org/10.1016/S1473-3099(20)30198-5. Dalton L, Rapa E, Stein A. Protecting the psychological health of through effective communication about COVID-19. Lancet Child Adolesc Health. 2020;4(5):346-347. https://doi.org/10.1016/S2352-4642(20)30097-3. Centre for Disease Control. Helping Children Cope with Emergencies. Available at: https://www.cdc.gov/childrenindisasters/helping-children-cope.html [Accessed on 25 August 2020]. Liu JJ, Bao Y, Huang X, Shi J, Lu L. Mental health considerations for children quarantined because of COVID-19. Lancet Child & Adolesc Health. 2020; 4(5):347-349. https://doi.org/10.1016/S2352-4642(20)30096-1. Sprang G, Silman M. Posttraumatic Stress Disorder in Parents and Youth After Health-Related Disasters. Disaster Med Public Health Prep. 2013;7(1):105-110. https://doi.org/10.1017/dmp.2013.22. Rehman U, Shahnawaz MG, Khan NH, Kharshiing KD, Khursheed M, Gupta K, et al. Depression, Anxiety and Stress Among Indians in Times of Covid-19 Lockdown. Community Ment Health J. 2020:1-7. https://doi.org/10.1007/s10597-020-00664-x. Cao W, Fang Z, Hou, Han M, Xu X, Dong J, et al. The psychological impact of the COVID-19 epidemic on college students in China. Psychiatry Research. 2020; 287:112934. https://doi.org/10.1016/j.psychres.2020.112934. Wang C, Zhao H. The Impact of COVID-19 on Anxiety in Chinese University Students. Front Psychol. 2020; 11:1168. https://dx.doi.org/10.3389%2Ffpsyg.2020.01168. Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, et al. The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus. Lancet Psychiatry 2020;7(3): e14. https://doi.org/10.1016/s2215-0366(20)30047-x. Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020;3(3): e203976. https://doi.org/10.1001/jamanetworkopen.2020.3976. Lancee WJ, Maunder RG, Goldbloom DS, Coauthors for the Impact of SARS Study. Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. Psychiatr Serv. 2008;59(1):91-95. https://dx.doi.org/10.1176%2Fps.2008.59.1.91. Tam CWC, Pang EPF, Lam LCW, Chiu HFK. Severe acute respiratory syndrome (SARS) in Hongkong in 2003: Stress and psychological impact among frontline healthcare workers. Psychol Med. 2004;34 (7):1197-1204. https://doi.org/10.1017/s0033291704002247. Lee SM, Kang WS, Cho A-R, Kim T, Park JK. Psychological impact of the 2015 MERS outbreak on hospital workers and quarantined hemodialysis patients. Compr Psychiatry. 2018; 87:123-127. https://dx.doi.org/10.1016%2Fj.comppsych.2018.10.003. Koh D, Meng KL, Chia SE, Ko SM, Qian F, Ng V, et al. Risk perception and impact of severe acute respiratory syndrome (SARS) on work and personal lives of healthcare workers in Singapore: What can we learn? Med Care. 2005;43(7):676-682. https://doi.org/10.1097/01.mlr.0000167181.36730.cc. Verma S, Mythily S, Chan YH, Deslypere JP, Teo EK, Chong SA. Post-SARS psychological morbidity and stigma among general practitioners and traditional Chinese medicine practitioners in Singapore. Ann Acad Med Singap. 2004; 33(6):743e8. Yeung J, Gupta S. Doctors evicted from their homes in India as fear spreads amid coronavirus lockdown. CNN World. 2020. Available at: https://edition.cnn.com/2020/03/25/asia/india-coronavirus-doctors-discrimination-intl-hnk/index.html. [Accessed on 24 August 2020] Violence Against Women and Girls: the Shadow Pandemic. UN Women. 2020. May 3, 2020. Available at: https://www.unwomen.org/en/news/stories/2020/4/statement-ed-phumzile-violence-against-women-during-pandemic. [Accessed on 24 August 2020]. Gearhart S, Patron MP, Hammond TA, Goldberg DW, Klein A, Horney JA. The impact of natural disasters on domestic violence: an analysis of reports of simple assault in Florida (1999–2007). Violence Gend. 2018;5(2):87–92. https://doi.org/10.1089/vio.2017.0077. Sahoo S, Rani S, Parveen S, Pal Singh A, Mehra A, Chakrabarti S, et al. Self-harm and COVID-19 pandemic: An emerging concern – A report of 2 cases from India. Asian J Psychiatr 2020; 51:102104. https://dx.doi.org/10.1016%2Fj.ajp.2020.102104. Ghosh A, Khitiz MT, Pandiyan S, Roub F, Grover S. Multiple suicide attempts in an individual with opioid dependence: Unintended harm of lockdown during the COVID-19 outbreak? Indian J Psychiatry 2020; [In Press]. The Economic Times. 11 Coronavirus suspects flee from a hospital in Maharashtra. March 16 2020. Available at: https://economictimes.indiatimes.com/news/politics-and-nation/11-coronavirus-suspects-flee-from-a-hospital-in-maharashtra/videoshow/74644936.cms?from=mdr. [Accessed on 23 August 2020]. Xiang Y, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. The Lancet Psychiatry 2020;(3):228–229. https://doi.org/10.1016/S2215-0366(20)30046-8. Van Bortel T, Basnayake A, Wurie F, Jambai M, Koroma A, Muana A, et al. Psychosocial effects of an Ebola outbreak at individual, community and international levels. Bull World Health Organ. 2016;94(3):210–214. https://dx.doi.org/10.2471%2FBLT.15.158543. Kumar A, Nayar KR. COVID 19 and its mental health consequences. Journal of Mental Health. 2020; ahead of print:1-2. https://doi.org/10.1080/09638237.2020.1757052. Gupta R, Grover S, Basu A, Krishnan V, Tripathi A, Subramanyam A, et al. Changes in sleep pattern and sleep quality during COVID-19 lockdown. Indian J Psychiatry. 2020; 62(4):370-8. https://doi.org/10.4103/psychiatry.indianjpsychiatry_523_20. Duan L, Zhu G. Psychological interventions for people affected by the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4): P300-302. https://doi.org/10.1016/S2215-0366(20)30073-0. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S et al. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020; 14(5): 779–788. https://dx.doi.org/10.1016%2Fj.dsx.2020.05.035. Wright R. The world's largest coronavirus lockdown is having a dramatic impact on pollution in India. CNN World; 2020. Available at: https://edition.cnn.com/2020/03/31/asia/coronavirus-lockdown-impact-pollution-india-intl-hnk/index.html. [Accessed on 23 August 2020] Foster O. ‘Lockdown made me Realise What’s Important’: Meet the Families Reconnecting Remotely. The Guardian; 2020. Available at: https://www.theguardian.com/keep-connected/2020/apr/23/lockdown-made-me-realise-whats-important-meet-the-families-reconnecting-remotely. (Accessed on 23 August 2020) Bilefsky D, Yeginsu C. Of ‘Covidivorces’ and ‘Coronababies’: Life During a Lockdown. N. Y. Times; 2020. Available at: https://www.nytimes.com/2020/03/27/world/coronavirus-lockdown-relationships.html [Accessed on 23 August 2020]

LANGUAGE NOTE | Document text in Chinese; abstract also in English. 魯迅(1881-1936)是我國現代小説重要的開拓者。他的小説，無論內容、形式、技巧，都突破傳統小説的規範，尤其敍述技巧方面，勇於作種種新的嘗試。他借鑑了西方的敍事觀點理論，靈活變化運用：每一種敍事觀點都加以試驗，相同的敍事觀點又加以變化運用，做成每一篇作品都有不同的形式。 《吶喊》和《彷徨》是魯迅創作小説的結集。本文就兩部小説集中二十五篇小説，逐一分析其敍述技巧；而所謂敍述技巧，主要是敍事觀點的選擇、運用，有時旁及敍述時間的操縱、調度。Lu Xun (1881-1936) is an important pioneer of Chinese modem fiction. The content, format, techniques of his novels are also breakthroughs to the canonical of traditional Chinese novels. He also made new attempts in his narrative techniques. He used the experience of the narrative viewpoint theory from the western novels and handled them with great flexibility. He experimented on each of the narrative viewpoint and applied them quick-wittedly on the same narrative viewpoint so that each piece of the novels has a different modality. "Cry Out” ('Na Han') and "Wandering" (‘Pang Wang') are the two collections of short novels of Lu Xun. This passage focuses on the analysis of the narrative viewpoints of the twenty five masterpieces one by one. The so-called narrative techniques are mainly the choice of narrative viewpoint. He might sometimes takes interest in the control and management of narrative time as well.

Books reviewed: China Yi‐Tsi Mei Feuerwerker, Ideology, Power, Text: self‐Representation and the Peasant ‘Other’ in Modern Chinese LiteraturePo‐Ching Yip and Don Rimmington, Basic Chinese: a Grammar and WorkbookVirginia Yip and Stephen Matthews, Basic Cantonese: a Grammar and WorkbookMary Ann Farquhar, Children's Literature in China: from Lu Xun to Mao ZedongRay Huang, Broadening the Horizons of Chinese History. Discourses, Syntheses, and ComparisonsGloria Heyung Chun, Of Orphans and Warriors: inventing Chinese American Culture & Identity Japan, Korea Purnendra Jain (ed), Australasian Studies of Japan: essays and Annotated Bibliography (1989–1996) South, West & Central Asia S. R. N. Murthy, Vedic View of the Earth—a Geological Insight into the VedasSubrata K. Mitra and V. B. Singh (eds), Democracy and Social Change in India: a Cross Sectional Analysis of the National Electorate Southeast Asia Albert Lau, A Moment of Anguish: Singapore in Malaysia and the Politics of DisengagementMichael D. Barr, Lee Kuan Yew: the Beliefs Behind the Man General Asia Hung‐Mao Tien and Tun‐Jen Cheng (Eds), The Security Environment in the Asia Pacific

Books reviewed in this article:Chiu–Yee Cheung, Lu Xun: the Chinese “Gentle” NietzschePamela Kyle Crossley, The ManchusGloria Davies (ed.), Voicing Concerns: Contemporary Chinese Critical InquiryAndrew F. Jones, Yellow Music—Media Culture and Colonial Modernity in the Chinese Jazz AgeKam Louie, Theorising Chinese MasculinityLung–Kee Sun, The Chinese National Character: From Nationhood to IndividualityMichael Lewis, Becoming Apart: National Power and Local Politics in Toyama, 1868–1945Michael Molasky and Steve Rabson (eds.), Southern Exposure: Modern Japanese Literature from OkinawaRajyashree Pandey, Writing and Renunciation in Medieval Japan: the Works of the Poet–Priest Kamo no ChōmeiTakamizawa Junko, My Brother Hideo KobayashiI. Qadeer, K. Sen and K. Nayar, Public Health and the Poverty of ReformJaved Ahmad Khan, India and West Asia: Emerging Markets in the Liberalisation EraPhilip J. Eldridge, The Politics of Human Rights in Southeast AsiaKasian Tejapira, Commodifying Marxism. The Formation of Modern Thai Radical Culture, 1927–1958Nicholas Tarling, A Sudden Rampage: the Japanese Occupation of Southeast Asia, 1941–1945B. A. Hussainmiya, The Brunei Constitution of 1959: an Inside HistoryDavid E. Pollard, The Chinese EssayEva Hung (ed), City Women: Contemporary Taiwan Women WritersP. J. Moore, A Concise History of Dutch Mauritius, 1598–1710: a Fruitful and Healthy LandHenry Yuhuai He, Dictionary of the Political Thought of the People's Republic of ChinaWilliam Duiker, Historical Dictionary of VietnamRizal Sukma, Indonesia and China: the Politics of a Troubled RelationshipNicholas Tarling (ed), Indonesia after SoehartoRoy Davis Linville Jumper, Orang Asli Now: the Orang Asli in the Malaysian Political WorldLiang Xiaosheng, Panic and Deaf: two Modern SatiresLeo Douw, Cen Huang and Michael R. Godley (eds), Qiaoxiang Ties: Interdisciplinary Approaches to ‘Cultural Capitalism’ in South ChinaCyril Birch, Scenes for Mandarins: the Elite Theatre of the MingJi Giles Ungpakorn, Thailand: Class Struggle in an Era of Economic CrisisJi Ungpakorn, The Struggle for Democracy and Social Justice in Thailand

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus , is causing a serious worldwide COVID-19 pandemic. The emergence of strains with rapid spread and unpredictable changes is the cause of the increase in morbidity and mortality rates. A number of drugs as well as vaccines are currently being used to relieve symptoms, prevent and treat the disease caused by this virus. However, the number of approved drugs is still very limited due to their effectiveness and side effects. In such a situation, medicinal plants and bioactive compounds are considered a highly valuable source in the development of new antiviral drugs against SARS-CoV-2. This review summarizes medicinal plants and bioactive compounds that have been shown to act on molecular targets involved in the infection and replication of SARS-CoV-2. Keywords: Medicinal plants, bioactive compounds, antivirus, SARS-CoV-2, COVID-19 References [1] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu et al., Genomic Characterisation and Epidemiology of 2019, Novel Coronavirus: Implications for Virus Origins and Receptor Binding, The Lancet, Vol. 395, 2020, pp. 565-574, https://doi.org/10.1016/S0140-6736(20)30251-8.[2] World Health Organization, WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int, 2021 (accessed on: August 27, 2021).[3] H. Wang, P. Yang, K. Liu, F. Guo, Y. Zhang et al., SARS Coronavirus Entry into Host Cells Through a Novel Clathrin- and Caveolae-Independent Endocytic Pathway, Cell Research, Vol. 18, No. 2, 2008, pp. 290-301, https://doi.org/10.1038/cr.2008.15.[4] A. Zumla, J. F. W. Chan, E. I. Azhar, D. S. C. Hui, K. Y. Yuen., Coronaviruses-Drug Discovery and Therapeutic Options, Nature Reviews Drug Discovery, Vol. 15, 2016, pp. 327-347, https://doi.org/10.1038/nrd.2015.37.[5] A. Prasansuklab, A. Theerasri, P. Rangsinth, C. Sillapachaiyaporn, S. Chuchawankul, T. Tencomnao, Anti-COVID-19 Drug Candidates: A Review on Potential Biological Activities of Natural Products in the Management of New Coronavirus Infection, Journal of Traditional and Complementary Medicine, Vol. 11, 2021, pp. 144-157, https://doi.org/10.1016/j.jtcme.2020.12.001.[6] R. E. Ferner, J. K. Aronson, Chloroquine and Hydroxychloroquine in Covid-19, BMJ, Vol. 369, 2020, https://doi.org/10.1136/bmj.m1432[7] J. Remali, W. M. Aizat, A Review on Plant Bioactive Compounds and Their Modes of Action Against Coronavirus Infection, Frontiers in Pharmacology, Vol. 11, 2021, https://doi.org/10.3389/fphar.2020.589044.[8] Y. Chen, Q. Liu, D. Guo, Emerging Coronaviruses: Genome Structure, Replication, and Pathogenesis, Medical Virology, Vol. 92, 2020, pp. 418‐423. https://doi.org/10.1002/jmv.25681.[9] B. Benarba, A. Pandiella, Medicinal Plants as Sources of Active Molecules Against COVID-19, Frontiers in Pharmacology, Vol. 11, 2020, https://doi.org/10.3389/fphar.2020.01189.[10] N. T. Chien, P. V. Trung, N. N. Hanh, Isolation Tribulosin, a Spirostanol Saponin from Tribulus terrestris L, Can Tho University Journal of Science, Vol. 10, 2008, pp. 67-71 (in Vietnamese).[11] V. Q. Thang Study on Extracting Active Ingredient Protodioscin from Tribulus terrestris L.: Doctoral dissertation, VNU University of Science, 2018 (in Vietnamese).[12] Y. H. Song, D. W. Kim, M. J. C. Long, H. J. Yuk, Y. Wang, N. Zhuang et al., Papain-Like Protease (Plpro) Inhibitory Effects of Cinnamic Amides from Tribulus terrestris Fruits, Biological and Pharmaceutical Bulletin, Vol. 37, No. 6, 2014, pp. 1021-1028, https://doi.org/10.1248/bpb.b14-00026.[13] D. Dermawan, B. A. Prabowo, C. A. Rakhmadina, In Silico Study of Medicinal Plants with Cyclodextrin Inclusion Complex as The Potential Inhibitors Against SARS-Cov-2 Main Protease (Mpro) and Spike (S) Receptor, Informatics in Medicine Unlocked, Vol. 25, 2021, pp. 1-18, https://doi.org/10.1016/j.imu.2021.100645.[14] R. Dang, S. Gezici, Immunomodulatory Effects of Medicinal Plants and Natural Phytochemicals in Combating Covid-19, The 6th International Mediterranean Symposium on Medicinal and Aromatic Plants (MESMAP-6), Izmir, Selcuk (Ephesus), Turkey, 2020, pp. 12-13.[15] G. Jiangning, W. Xinchu, W. Hou, L. Qinghua, B. Kaishun, Antioxidants from a Chinese Medicinal Herb–Psoralea corylifolia L., Food Chemistry, Vol. 9, No. 2, 2005, pp. 287-292, https://doi.org/10.1016/j.foodchem.2004.04.029.[16] B. Ruan, L. Y. Kong, Y. Takaya, M. Niwa, Studies on The Chemical Constituents of Psoralea corylifolia L., Journal of Asian Natural Products Research, Vol. 9, No. 1, 2007, pp. 41-44, https://doi.org/10.1080/10286020500289618.[17] D. T. Loi, Vietnamese Medicinal Plants and Herbs, Medical Publishing House, Hanoi, 2013 (in Vietnamese).[18] S. Mazraedoost, G. Behbudi, S. M. Mousavi, S. A. Hashemi, Covid-19 Treatment by Plant Compounds, Advances in Applied NanoBio-Technologies, Vol. 2, No. 1, 2021, pp. 23-33, https://doi.org/10.47277/AANBT/2(1)33.[19] B. A. Origbemisoye, S. O. Bamidele, Immunomodulatory Foods and Functional Plants for COVID-19 Prevention: A Review, Asian Journal of Medical Principles and Clinical Practice, 2020, pp. 15-26, https://journalajmpcp.com/index.php/AJMPCP/article/view/30124[20] A. Mandal, A. K. Jha, B. Hazra, Plant Products as Inhibitors of Coronavirus 3CL Protease, Frontiers in Pharmacology, Vol. 12, 2021, pp. 1-16, https://doi.org/10.3389/fphar.2021.583387[21] N. H. Tung, V. D. Loi, B. T. Tung, L.Q. Hung, H. B. Tien et al., Triterpenen Ursan Frame Isolated from the Roots of Salvia Miltiorrhiza Bunge Growing in Vietnam, VNU Journal of Science: Medical and Pharmaceutical Sciences, Vol. 32, No. 2, 2016, pp. 58-62, https://js.vnu.edu.vn/MPS/article/view/3583 (in Vietnamese).[22] J. Y. Park, J. H. Kim, Y. M. Kim, H. J. Jeong, D. W. Kim, K. H. Park et al., Tanshinones as Selective and Slow-Binding Inhibitors for SARS-CoV Cysteine Proteases. Bioorganic and Medicinal Chemistry, Vol. 20, No. 19, 2012, pp. 5928-5935, https://doi.org/10.1016/j.bmc.2012.07.038.[23] F. Hamdani, N. Houari, Phytotherapy of Covid-19. A Study Based on a Survey in North Algeria, Phytotherapy, Vol. 18, No. 5, 2020, pp. 248-254, https://doi.org/10.3166/phyto-2020-0241.[24] P. T. L. Huong, N. T. Dinh, Chemical Composition And Antibacterial Activity of The Essential Oil From The Leaves of Regrowth Eucalyptus Collected from Viet Tri City, Phu Tho Province, Vietnam Journal of Science, Technology and Engineering, Vol. 18, No. 1, 2020, pp. 54-61 (in Vietnamese).[25] M. Asif, M. Saleem, M. Saadullah, H. S. Yaseen, R. Al Zarzour, COVID-19 and Therapy with Essential Oils Having Antiviral, Anti-Inflammatory, and Immunomodulatory Properties, Inflammopharmacology, Vol. 28, 2020, pp. 1153-1161, https://doi.org/10.1007/s10787-020-00744-0.[26] I. Jahan, O. Ahmet, Potentials of Plant-Based Substance to Inhabit and Probable Cure for The COVID-19, Turkish Journal of Biology, Vol. 44, No. SI-1, 2020, pp. 228-241, https://doi.org/10.3906/biy-2005-114.[27] A. D. Sharma, I. Kaur, Eucalyptus Essential Oil Bioactive Molecules from Against SARS-Cov-2 Spike Protein: Insights from Computational Studies, Res Sq., 2021, pp. 1-6, https://doi.org/10.21203/ rs.3.rs-140069/v1. [28] K. Rajagopal, P. Varakumar, A. Baliwada, G. Byran, Activity of Phytochemical Constituents of Curcuma Longa (Turmeric) and Andrographis Paniculata Against Coronavirus (COVID-19): An in Silico Approach, Future Journal of Pharmaceutical Sciences, Vol. 6, No. 1, 2020, pp. 1-10, https://doi.org/10.1186/s43094-020-00126-x[29] J. Lan, J. Ge, J. Yu, S. Shan, H. Zhou, S. Fan et al., Structure of The SARS-CoV-2 Spike Receptor-Binding Domain Bound to The ACE2 Receptor, Nature, Vol. 581, No. 7807, 2020, pp. 215-220, https://doi.org/10.1038/s41586-020-2180-5.[30] M. Letko, A. Marzi, V. Munster, Functional Assessment of Cell Entry and Receptor Usage for SARS-Cov-2 and Other Lineage B Betacoronaviruses, Nature Microbiology, Vol. 5, No. 4, 2020, pp. 562-569, https://doi.org/10.1038/s41564-020-0688-y.[31] C. Yi, X. Sun, J. Ye, L. Ding, M. Liu, Z. Yang et al., Key Residues of The Receptor Binding Motif in The Spike Protein of SARS-Cov-2 That Interact with ACE2 and Neutralizing Antibodies, Cellular and Molecular Immunology, Vol. 17, No. 6, 2020, pp. 621-630, https://doi.org/10.1038/s41423-020-0458-z.[32] N. T. Thom, Study on The Composition and Biological Activities of Flavonoids from The Roots of Scutellaria baicalensis: Doctoral Dissertation, Hanoi University of Science and Technology, 2018 (in Vietnamese).[33] Y. J. Tang, F. W. Zhou, Z. Q. Luo, X. Z. Li, H. M. Yan, M. J. Wang et al., Multiple Therapeutic Effects of Adjunctive Baicalin Therapy in Experimental Bacterial Meningitis, Inflammation, Vol. 33, No. 3, 2010, pp. 180-188, https://doi.org/10.1007/s10753-009-9172-9.[34] H. Liu, F. Ye, Q. Sun, H. Liang, C. Li, S. Li et al., Scutellaria Baicalensis Extract and Baicalein Inhibit Replication of SARS-Cov-2 and Its 3C-Like Protease in Vitro, Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 36, No. 1, 2021, pp. 497-503, https://doi.org/10.1080/14756366.2021.1873977.[35] Z. Iqbal, H. Nasir, S. Hiradate, Y. Fujii, Plant Growth Inhibitory Activity of Lycoris Radiata Herb. and The Possible Involvement of Lycorine as an Allelochemical, Weed Biology and Management, Vol. 6, No. 4, 2006, pp. 221-227, https://doi.org/10.1111/j.1445-6664.2006.00217.x.[36] S. Y. Li, C. Chen, H. Q. Zhang, H. Y. Guo, H. Wang, L. Wang et al., Identification of Natural Compounds with Antiviral Activities Against SARS-Associated Coronavirus, Antiviral Research, Vol. 67, No. 1, 2005, pp. 18-23, https://doi.org/10.1016/j.antiviral.2005.02.007.[37] S. Kretzing, G. Abraham, B. Seiwert, F. R. Ungemach, U. Krügel, R. Regenthal, Dose-dependent Emetic Effects of The Amaryllidaceous Alkaloid Lycorine in Beagle Dogs, Toxicon, Vol. 57, No. 1, 2011, pp. 117-124, https://doi.org/10.1016/j.toxicon.2010.10.012.[38] Y. N. Zhang, Q. Y. Zhang, X. D. Li, J. Xiong, S. Q. Xiao, Z. Wang, et al., Gemcitabine, Lycorine and Oxysophoridine Inhibit Novel Coronavirus (SARS-Cov-2) in Cell Culture, Emerging Microbes & Infections, Vol. 9, No. 1, 2020, pp. 1170-1173, https://doi.org/10.1080/22221751.2020.1772676.[39] Y. H. Jin, J. S. Min, S. Jeon, J. Lee, S. Kim, T. Park et al., Lycorine, a Non-Nucleoside RNA Dependent RNA Polymerase Inhibitor, as Potential Treatment for Emerging Coronavirus Infections, Phytomedicine, Vol. 86, 2021, pp. 1-8, https://doi.org/10.1016/j.phymed.2020.153440.[40] H. V. Hoa, P. V. Trung, N. N. Hanh, Isolation Andrographolid and Neoandrographolid from Andrographis Paniculata Nees, Can Tho University Journal of Science, Vol. 10, 2008, pp. 25-30 (in Vietnamese)[41] S. K. Enmozhi, K. Raja, I. Sebastine, J. Joseph, Andrographolide as a Potential Inhibitor Of SARS-Cov-2 Main Protease: An in Silico Approach, Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 9, 2021, pp. 3092-3098, https://doi.org/10.1080/07391102.2020.1760136.[42] S. A. Lakshmi, R. M. B. Shafreen, A. Priya, K. P. Shunmugiah, Ethnomedicines of Indian Origin for Combating COVID-19 Infection by Hampering The Viral Replication: Using Structure-Based Drug Discovery Approach, Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 13, 2020, pp. 4594-4609, https://doi.org/10.1080/07391102.2020.1778537.[43] N. P. L. Laksmiani, L. P. F. Larasanty, A. A. G. J. Santika, P. A. A. Prayoga, A. A. I. K. Dewi, N. P. A. K. Dewi, Active Compounds Activity from The Medicinal Plants Against SARS-Cov-2 Using in Silico Assay, Biomedical and Pharmacology Journal, Vol. 13, No. 2, 2020, pp. 873-881, https://dx.doi.org/10.13005/bpj/1953.[44] N. A. Murugan, C. J. Pandian, J. Jeyakanthan, Computational Investigation on Andrographis Paniculata Phytochemicals to Evaluate Their Potency Against SARS-Cov-2 in Comparison to Known Antiviral Compounds in Drug Trials, Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 12, 2020, pp. 4415-4426, https://doi.org/10.1080/07391102.2020.1777901.[45] S. Hiremath, H. V. Kumar, M. Nandan, M. Mantesh, K. Shankarappa,V. Venkataravanappa et al., In Silico Docking Analysis Revealed The Potential of Phytochemicals Present in Phyllanthus Amarus and Andrographis Paniculata, Used in Ayurveda Medicine in Inhibiting SARS-Cov-2, 3 Biotech, Vol. 11, No. 2, 2021, pp. 1-18, https://doi.org/10.1007/s13205-020-02578-7.[46] K. S. Ngiamsuntorn, A. Suksatu, Y. Pewkliang, P. Thongsri, P. Kanjanasirirat, S. Manopwisedjaroen, et al., Anti-SARS-Cov-2 Activity of Andrographis Paniculata Extract and Its Major Component Andrographolide in Human Lung Epithelial Cells and Cytotoxicity Evaluation in Major Organ Cell Representatives, Journal of Natural Products, Vol. 84, No. 4, 2021, pp. 1261-1270, https://doi.org/10.1021/acs.jnatprod.0c01324.[47] D. X. Em, N. T. T. Dai, N. T. T. Tram, D. X. Chu, Four Compounds Isolated from Azadirachta Indica Jus leaves. F., Meliaceae, Pharmaceutical Journal, Vol. 59, No. 7, 2019, pp. 33-36 (in Vietnamese).[48] V. V Do, N. T. Thang, N. T. Minh, N. N. Hanh, Isolation, Purification and Investigation on Antimicrobial Activity of Salanin from Neem Seed Kernel (Azadirachta Indica A. Juss) of The Neem Tree Planted in Ninh Thuan Province, Vietnam, Journal of Science and Technology, Vol. 44, No. 2, 2006, pp. 24-31 (in Vietnamese).[49] P. I. Manzano Santana, J. P. P. Tivillin, I. A. Choez Guaranda, A. D. B. Lucas, A. Katherine, Potential Bioactive Compounds of Medicinal Plants Against New Coronavirus (SARS-Cov-2): A Review, Bionatura, Vol. 6, No. 1, 2021, pp. 1653-1658, https://doi.org/10.21931/RB/2021.06.01.30[50] S. Borkotoky, M. Banerjee, A Computational Prediction of SARS-Cov-2 Structural Protein Inhibitors from Azadirachta Indica (Neem), Journal of Biomolecular Structure and Dynamics, Vol. 39, No. 11, 2021, pp. 4111-4121, https://doi.org/10.1080/07391102.2020.1774419.[51] R. Jager, R. P. Lowery, A. V. Calvanese, J. M. Joy, M. Purpura, J. M. Wilson, Comparative Absorption of Curcumin Formulations, Nutrition Journal, Vol. 13, No. 11, 2014, https://doi.org/10.1186/1475-2891-13-11.[52] D. Praditya, L. Kirchhoff, J. Bruning, H. Rachmawati, J. Steinmann, E. Steinmann, Anti-infective Properties of the Golden Spice Curcumin, Front Microbiol, Vol. 10, No. 912, 2019, https://doi.org/10.3389/fmicb.2019.00912.[53] C. C. Wen, Y. H. Kuo, J. T. Jan, P. H. Liang, S. Y. Wang, H. G. Liu et al., Specific Plant Terpenoids and Lignoids Possess Potent Antiviral Activities Against Severe Acute Respiratory Syndrome Coronavirus, Journal of Medicinal Chemistry, Vol. 50, No. 17, 2007, pp. 4087-4095, https://doi.org/10.1021/jm070295s.[54] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu et al., Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding, The Lancet, Vol. 395, No. 10224, 2020, pp. 565-574, https://doi.org/10.1016/S0140-6736(20)30251-8.[55] M. Kandeel, M. Al Nazawi, Virtual Screening and Repurposing of FDA Approved Drugs Against COVID-19 Main Protease, Life Sciences, Vol. 251, No. 117627, 2020, pp. 1-5, https://doi.org/10.1016/j.lfs.2020.117627.[56] V. K. Maurya, S. Kumar, A. K. Prasad, M. L. B. Bhatt, S. K. Saxena, Structure-Based Drug Designing for Potential Antiviral Activity of Selected Natural Products from Ayurveda Against SARS-CoV-2 Spike Glycoprotein and Its Cellular Receptor, Virusdisease, Vol. 31, No. 2, 2020, pp. 179-193, https://doi.org/10.1007/s13337-020-00598-8.[57] M. Hoffmann, H. Kleine Weber, S. Schroeder, N. Kruger, T. Herrler, S. Erichsen et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, Vol. 181, No. 2, 2020, pp. 271-280, https://doi.org/10.1016/j.cell.2020.02.052.[58] S. Katta, A. Srivastava, R. L. Thangapazham, I. L. Rosner, J. Cullen, H. Li et al., Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells, International Journal of Molecular Sciences, Vol. 20, No. 19, 2019, pp. 4891-4907, https://doi.org/10.3390/ijms20194891.[59] D. Ting, N. Dong, L. Fang, J. Lu, J. Bi, S. Xiao et al., Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin, ACS Applied Nano Materials, Vol. 1, No. 10, 2018, pp. 5451-5459, https://doi.org/10.1021/acsanm.8b00779.[60] T. Huynh, H. Wang, B. Luan, In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2's Main Protease, the Journal of Physical Chemistry Letters, Vol. 11, No. 11, 2020, pp. 4413-4420, https://doi.org/10.1021/acs.jpclett.0c00994.[61] D. D'Ardes, A. Boccatonda, I. Rossi, M. T. Guagnano, COVID-19 and RAS: Unravelling an Unclear Relationship, International Journal of Molecular Sciences, Vol. 21, No. 8, 2020, pp. 3003-3011, https://doi.org/10.3390/ijms21083003. [62] X. F. Pang, L. H. Zhang, F. Bai, N. P. Wang, R. E. Garner, R. J. McKallip et al., Attenuation of Myocardial Fibrosis with Curcumin is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats, Drug Design Development Therapy, Vol. 9, 2015, pp. 6043-6054, https://doi.org/10.2147/DDDT.S95333.[63] Y. Yao, W. Wang, M. Li, H. Ren, C. Chen, J. Wang et al., Curcumin Exerts its Anti-Hypertensive Effect by Down-Regulating the AT1 Receptor in Vascular Smooth Muscle Cells, Scientific Reports, Vol. 6, No. 25579, 2016, pp. 1-6, https://doi.org/10.1038/srep25579.[64] V. J. Costela Ruiz, R. Illescas Montes, J. M. Puerta Puerta, C. Ruiz, L. Melguizo Rodríguez, SARS-CoV-2 Infection: The Role of Cytokines in COVID-19 Disease, Cytokine Growth Factor Reviews, Vol. 54, 2020, pp. 62-75, https://doi.org/10.1016/j.cytogfr.2020.06.001.[65] H. Valizadeh, S. Abdolmohammadi Vahid, S. Danshina, M. Ziya Gencer, A. Ammari, A. Sadeghi et al., Nano-Curcumin Therapy, a Promising Method in Modulating Inflammatory Cytokines in COVID-19 Patients, International Immunopharmacology, Vol. 89 (PtB), No. 107088, 2020, pp. 1-12, https://doi.org/10.1016/j.intimp.2020.107088.[66] Y. H. Lo, R. D. Lin, Y. P. Lin, Y. L. Liu, M. H. Lee, Active Constituents from Sophora Japonica Exhibiting Cellular Tyrosinase Inhibition in Human Epidermal Melanocytes, Journal of Ethnopharmacology, Vol. 124, No. 3, 2009, pp. 625-629, https://doi.org/10.1016/j.jep.2009.04.053.[67] A. Robaszkiewicz, A. Balcerczyk, G. Bartosz, Antioxidative and Prooxidative Effects of Quercetin on A549 Cells, Cell Biology International, Vol. 31, No. 10, 2007, pp. 1245-1250, https://doi.org/10.1016/j.cellbi.2007.04.009[68] N. Uchide, H. Toyoda, Antioxidant Therapy as a Potential Approach to Severe Influenza-associated Complications, Molecules (Basel, Switzerland), Vol. 16, No. 3, 2011, pp. 2032-2052, https://doi.org/10.3390/molecules16032032.[69] M. P. Nair, C. Kandaswami, S. Mahajan, K. C. Chadha, R. Chawda, H. Nair et al., The Flavonoid, Quercetin, Differentially Regulates Th-1 (IFNgamma) and Th-2 (IL4) Cytokine Gene Expression by Normal Peripheral Blood Mononuclear Cells, Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1593, No. 1, 2002, pp. 29-36, https://doi.org/10.1016/s0167-4889(02)00328-2.[70] X. Chen, Z. Wang, Z. Yang, J. Wang, Y. Xu, R. X. Tan et al., Houttuynia Cordata Blocks HSV Infection Through Inhibition of NF-κB Activation, Antiviral Research, Vol. 92, No. 2, 2011, pp. 341-345, https://doi.org/10.1016/j.antiviral.2011.09.005.[71] T. N. Kaul, E. J. Middleton, P. L. Ogra, Antiviral Effect of Flavonoids on Human Viruses, Journal of Medical Virology, Vol. 15. No. 1, 1985, pp. 71-79, https://doi.org/10.1002/jmv.1890150110.[72] K. Zandi, B. T. Teoh, S. S. Sam, P. F. Wong, M. R. Mustafa, S. AbuBakar, Antiviral Activity of Four Types of Bioflavonoid Against Dengue Virus Type-2, Virology Journal, Vol. 8, No. 1, 2011, pp. 560-571, https://doi.org/10.1186/1743-422X-8-560.[73] J. Y. Park, H. J. Yuk, H. W. Ryu, S. H. Lim, K. S. Kim, K. H. Park et al., Evaluation of Polyphenols from Broussonetia Papyrifera as Coronavirus Protease Inhibitors, Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 32, No. 1, 2017, pp. 504-515, https://doi.org/10.1080/14756366.2016.1265519.[74] S. C. Cheng, W. C. Huang, J. H. S. Pang, Y. H. Wu, C. Y. Cheng, Quercetin Inhibits the Production of IL-1β-Induced Inflammatory Cytokines and Chemokines in ARPE-19 Cells via the MAPK and NF-κB Signaling Pathways, International Journal of Molecular Sciences, Vol. 20, No. 12, 2019, pp. 2957-2981, https://doi.org/10.3390/ijms20122957. [75] O. J. Lara Guzman, J. H. Tabares Guevara, Y. M. Leon Varela, R. M. Álvarez, M. Roldan, J. A. Sierra et al., Proatherogenic Macrophage Activities Are Targeted by The Flavonoid Quercetin, The Journal of Pharmacology and Experimental Therapeutics, Vol. 343, No. 2, 2012, pp. 296-303, https://doi.org/10.1124/jpet.112.196147.[76] A. Saeedi Boroujeni, M. R. Mahmoudian Sani, Anti-inflammatory Potential of Quercetin in COVID-19 Treatment, Journal of Inflammation, Vol. 18, No. 1, 2021, pp. 3-12, https://doi.org/10.1186/s12950-021-00268-6.[77] M. Smith, J. C. Smith, Repurposing Therapeutics for COVID-19: Supercomputer-based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-human ACE2 Interface, ChemRxiv, 2020, pp. 1-28, https://doi.org/10.26434/chemrxiv.11871402.v4.[78] S. Khaerunnisa, H. Kurniawan, R. Awaluddin, S. Suhartati, S. Soetjipto, Potential Inhibitor of COVID-19 Main Protease (Mpro) from Several Medicinal Plant Compounds by Molecular Docking Study, Preprints, 2020, pp. 1-14, https://doi.org/10.20944/preprints202003.0226.v1.[79] J. M. Calderón Montaño, E. B. Morón, C. P. Guerrero, M. L. Lázaro, A Review on the Dietary Flavonoid Kaempferol, Mini Reviews in Medicinal Chemistry, Vol. 11, No. 4, 2011, pp. 298-344, https://doi.org/10.2174/138955711795305335.[80] A. Y. Chen, Y. C. Chen, A Review of the Dietary Flavonoid, Kaempferol on Human Health and Cancer Chemoprevention, Food Chem, Vol. 138, No. 4, 2013, pp. 2099-2107, https://doi.org/10.1016/j.foodchem.2012.11.139.[81] S. Schwarz, D. Sauter, W. Lu, K. Wang, B. Sun, T. Efferth et al., Coronaviral Ion Channels as Target for Chinese Herbal Medicine, Forum on Immunopathological Diseases and Therapeutics, Vol. 3, No. 1, 2012, pp. 1-13, https://doi.org/10.1615/ForumImmunDisTher.2012004378.[82] R. Zhang, X. Ai, Y. Duan, M. Xue, W. He, C. Wang et al., Kaempferol Ameliorates H9N2 Swine Influenza Virus-induced Acute Lung Injury by Inactivation of TLR4/MyD88-mediated NF-κB and MAPK Signaling Pathways, Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, Vol. 89, 2017, pp. 660-672, https://doi.org/10.1016/j.biopha.2017.02.081.[83] K. W. Chan, V. T. Wong, S. C. W. Tang, COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease, The American Journal of Chinese medicine, Vol. 48, No. 3, 2020, pp. 737-762, https://doi.org/10.1142/S0192415X20500378.[84] Y. F. Huang, C. Bai, F. He, Y. Xie, H. Zhou, Review on the Potential Action Mechanisms of Chinese Medicines in Treating Coronavirus Disease 2019 (COVID-19), Pharmacological Research, Vol. 158, No. 104939, 2020, pp. 1-10, https://doi.org/10.1016/j.phrs.2020.104939.[85] L. Xu, X. Zheng, Y. Wang, Q. Fan, M. Zhang, R. Li et al., Berberine Protects Acute Liver Failure in Mice Through Inhibiting Inflammation and Mitochondria-dependent Apoptosis, European Journal of Pharmacology, Vol. 819, 2018, pp. 161-168, https://doi.org/10.1016/j.ejphar.2017.11.013.[86] X. Chen, H. Guo, Q. Li, Y. Zhang, H. Liu, X. Zhang et al., Protective Effect of Berberine on Aconite‑induced Myocardial Injury and the Associated Mechanisms, Molecular Medicine Reports, Vol. 18, No. 5, 2018, pp. 4468-4476, https://doi.org/10.3892/mmr.2018.9476.[87] K. Hayashi, K. Minoda, Y. Nagaoka, T. Hayashi, S. Uesato, Antiviral Activity of Berberine and Related Compounds Against Human Cytomegalovirus, Bioorganic & Medicinal Chemistry Letters, Vol. 17, No. 6, 2007, pp. 1562-1564, https://doi.org/10.1016/j.bmcl.2006.12.085.[88] A. Warowicka, R. Nawrot, A. Gozdzicka Jozefiak, Antiviral Activity of Berberine, Archives of Virology, Vol. 165, No. 9, 2020, pp. 1935-1945, https://doi.org/10.1007/s00705-020-04706-3.[89] Z. Z. Wang, K. Li, A. R. Maskey, W. Huang, A. A. Toutov, N. Yang et al., A Small Molecule Compound Berberine as an Orally Active Therapeutic Candidate Against COVID-19 and SARS: A Computational and Mechanistic Study, FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, Vol. 35, No. 4, 2021, pp. e21360-21379, https://doi.org/10.1096/fj.202001792R.[90] A. Pizzorno, B. Padey, J. Dubois, T. Julien, A. Traversier, V. Dulière et al., In Vitro Evaluation of Antiviral Activity of Single and Combined Repurposable Drugs Against SARS-CoV-2, Antiviral Research, Vol. 181, No. 104878, 2020, https://doi.org/10.1016/j.antiviral.2020.104878.[91] B. Y. Zhang, M. Chen, X. C. Chen, K. Cao, Y. You, Y. J. Qian et al., Berberine Reduces Circulating Inflammatory Mediators in Patients with Severe COVID-19, The British Journal of Surgery, Vol. 108, No. 1, 2021, pp. e9-e11, https://doi.org/10.1093/bjs/znaa021.[92] K. P. Latté, K. E. Appel, A. Lampen, Health Benefits and Possible Risks of Broccoli - an Overview, Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association, Vol. 49, No. 12, 2011, pp. 3287-3309, https://doi.org/10.1016/j.fct.2011.08.019.[93] C. Sturm, A. E. Wagner, Brassica-Derived Plant Bioactives as Modulators of Chemopreventive and Inflammatory Signaling Pathways, International Journal of Molecular Sciences, Vol. 18, No. 9, 2017, pp. 1890-1911, https://doi.org/10.3390/ijms18091890.[94] R. T. Ruhee, S. Ma, K. Suzuki, Sulforaphane Protects Cells against Lipopolysaccharide-Stimulated Inflammation in Murine Macrophages, Antioxidants (Basel, Switzerland), Vol. 8, No. 12, 2019, pp. 577-589, https://doi.org/10.3390/antiox8120577.[95] S. M. Ahmed, L. Luo, A. Namani, X. J. Wang, X. Tang, Nrf2 Signaling Pathway: Pivotal Roles in Inflammation, Biochimica et Biophysica Acta Molecular Basis of Disease, Vol. 1863, No. 2, 2017, pp. 585-597, https://doi.org/10.1016/j.bbadis.2016.11.005.[96] Z. Sun, Z. Niu, S. Wu, S. Shan, Protective Mechanism of Sulforaphane in Nrf2 and Anti-Lung Injury in ARDS Rabbits, Experimental Therapeutic Medicine, Vol. 15, No. 6, 2018, pp. 4911-4951, https://doi.org/10.3892/etm.2018.6036.[97] H. Y. Cho, F. Imani, L. Miller DeGraff, D. Walters, G. A. Melendi, M. Yamamoto et al., Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease, American Journal of Respiratory and Critical Care Medicine, Vol. 179, No. 2, 2009, pp. 138-150, https://doi.org/10.1164/rccm.200804-535OC.[98] M. J. Kesic, S. O. Simmons, R. Bauer, I. Jaspers, Nrf2 Expression Modifies Influenza A Entry and Replication in Nasal Epithelial Cells, Free Radical Biology & Medicine, Vol. 51, No. 2, 2011, pp. 444-453, https://doi.org/10.1016/j.freeradbiomed.2011.04.027.[99] A. Cuadrado, M. Pajares, C. Benito, J. J. Villegas, M. Escoll, R. F. Ginés et al., Can Activation of NRF2 Be a Strategy Against COVID-19?, Trends in Pharmacological Sciences, Vol. 41, No. 9, 2020, pp. 598-610, https://doi.org/10.1016/j.tips.2020.07.003.[100] J. Gasparello, E. D'Aversa, C. Papi, L. Gambari, B. Grigolo, M. Borgatti et al., Sulforaphane Inhibits the Expression of Interleukin-6 and Interleukin-8 Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein, Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, Vol. 87, No. 53583, 2021, https://doi.org/10.1016/j.phymed.2021.153583.

Alloys used in engines are subjected to challenging environments characterized by thermal and mechanical cyclic loadings during start-up and shut-down processes. These conditions can significantly increase the occurrence of fatigue failure mechanisms. Therefore, this study focuses on investigating the low cycle fatigue (LCF) behavior of directionally-solidified alloy at two distinct temperatures, namely 600 °C and 800 °C. Strain-controlled LCF tests were conducted at the specified temperatures, utilizing constant total strain amplitudes of 0.4%, 0.6%, 0.8%, and 1% under a totally reversed loading ratio (R = -1). The Coffin-Manson model, based on plastic deformation, along with a hysteresis energy-based criterion model, were employed to predict and evaluate fatigue life and LCF behavior. Notably, the hysteresis energy and Coffin-Manson models exhibited superior capability in predicting LCF life at 800 °C compared to 600 °C. REFERENCES Salehnasab, J. Marzbanrad, E. Poursaeidi, Transient thermal fatigue crack propagation prediction in a gas turbine component, Eng. Fail. Anal. 130 (2021) 105781. https://doi.org/10.1016/j.engfailanal.2021.105781. S.K. Balam, M. Tamilselvi, A.K. Mondal, R. Rajendran, An investigation into the cracking of platinum aluminide coated directionally solidified CM247 LC high pressure nozzle guide vanes of an aero engine, Eng. Fail. Anal. 94 (2018) 24–32. https://doi.org/10.1016/j.engfailanal.2018.07.027. M. Martinez-Esnaola, M. Arana, J. Bressers, J. Timm, A. Martin-Meizoso, A. Bennett, E.E. Affeldt, Crack initiation in an aluminide coated single crystal during thermomechanical fatigue, ASTM Spec. Tech. Publ. 1263 (1996) 68–81. https://doi.org/10.1520/STP16447S. Schlesinger, T. Seifert, J. Preussner, Experimental investigation of the time and temperature dependent growth of fatigue cracks in Inconel 718 and mechanism based lifetime prediction, Int. J. Fatigue. 99 (2017) 242–249. https://doi.org/10.1016/j.ijfatigue.2016.12.015. Furrer, H. Fecht, Ni-based superalloys for turbine discs, Jom. 51 (1999) 14–17. https://doi.org/10.1007/s11837-999-0005-y. Salehnasab, D. Zarifpour, J. Marzbanrad, G. Samimi, An Investigation into the fracture behavior of the IN625 hot-rolled superalloy, J. Mater. Eng. Perform. 30 (2021) 7171–7184. https://doi.org/https://doi.org/10.1007/s11665-021-05895-x. Caron, T. Khan, Evolution of Ni-based superalloys for single crystal gas turbine blade applications, Aerosp. Sci. Technol. 3 (1999) 513–523. https://doi.org/10.1016/S1270-9638(99)00108-X. Slámečka, J. Pokluda, M. Kianicová, J. Horníková, K. Obrtlík, Fatigue life of cast Inconel 713LC with/without protective diffusion coating under bending, torsion and their combination, Eng. Fract. Mech. 110 (2013) 459–467. https://doi.org/10.1016/j.engfracmech.2013.01.001. Rajendran, M.D. Ganeshachar, T.M. Rao, Condition assessment of gas turbine blades and coatings, Eng. Fail. Anal. 18 (2011) 2104–2110. https://doi.org/10.1016/j.engfailanal.2011.06.017. K. Bhaumik, M. Sujata, M.A. Venkataswamy, M.A. Parameswara, Failure of a low pressure turbine rotor blade of an aeroengine, Eng. Fail. Anal. 13 (2006) 1202–1219. https://doi.org/10.1016/j.engfailanal.2005.12.002. F. Nie, Z.L. Liu, X.M. Liu, Z. Zhuang, Size effects of γ′ precipitate on the creep properties of directionally solidified nickel-base super-alloys at middle temperature, Comput. Mater. Sci. 46 (2009) 400–406. https://doi.org/10.1016/j.commatsci.2009.03.023. Min, X. Wu, L. Xu, W. Tang, S. Zhang, G. Wallner, D. Liang, Y. Feng, Influence of different surface treatments of H13 hot work die steel on its thermal fatigue behaviors, J. Shanghai Univ. (English Ed. 5 (2001) 326–330. https://doi.org/10.1007/s11741-001-0049-x. K. Rai, J.K. Sahu, S.K. Das, N. Paulose, D.C. Fernando, C. Srivastava, Cyclic plastic deformation behaviour of a directionally solidified nickel base superalloy at 850° C: damage micromechanisms, Mater. Charact. 141 (2018) 120–128. https://doi.org/10.1016/j.matchar.2018.04.039. Zhang, L.G. Zhao, A. Roy, V. V Silberschmidt, G. Mccolvin, Low-cycle fatigue of single crystal nickel-based superalloy–mechanical testing and TEM characterisation, Mater. Sci. Eng. A. 744 (2019) 538–547. https://doi.org/10.1016/j.msea.2018.12.084. Qu, C.M. Fu, C. Dong, J.F. Tian, Z.F. Zhang, Failure analysis of the 1st stage blades in gas turbine engine, Eng. Fail. Anal. 32 (2013) 292–303. https://doi.org/10.1016/j.engfailanal.2013.03.017. Salehnasab, E. Poursaeidi, S.A. Mortazavi, G.H. Farokhian, Hot corrosion failure in the first stage nozzle of a gas turbine engine, Eng. Fail. Anal. 60 (2016). https://doi.org/10.1016/j.engfailanal.2015.11.057. Kumari, D.V. V Satyanarayana, M. Srinivas, Failure analysis of gas turbine rotor blades, Eng. Fail. Anal. 45 (2014) 234–244. https://doi.org/10.1016/j.engfailanal.2014.06.003. J. Carter, Common failures in gas turbine blades, Eng. Fail. Anal. 12 (2005) 237–247. https://doi.org/10.1016/j.engfailanal.2004.07.004. Salehnasab, E. Poursaeidi, Mechanism and modeling of fatigue crack initiation and propagation in the directionally solidified CM186 LC blade of a gas turbine engine, Eng. Fract. Mech. 225 (2020) 106842. https://doi.org/10.1016/j.engfracmech.2019.106842. I. Stephens, A. Fatemi, R.R. Stephens, H.O. Fuchs, Metal fatigue in engineering, John Wiley & Sons, 2000. Salehnasab, J. Marzbanrad, E. Poursaeidi, Conventional shot peening treatment effects on thermal fatigue crack growth and failure mechanisms of a solid solution alloy, Eng. Fail. Anal. 155 (2024) 107740. https://doi.org/10.1016/j.engfailanal.2023.107740. Prasad, R. Sarkar, P. Ghosal, V. Kumar, M. Sundararaman, High temperature low cycle fatigue deformation behaviour of forged IN 718 superalloy turbine disc, Mater. Sci. Eng. A. 568 (2013) 239–245. https://doi.org/10.1016/j.msea.2012.12.069. Cano, J.A. Rodríguez, J.M. Rodríguez, J.C. García, F.Z. Sierra, S.R. Casolco, M. Herrera, Detection of damage in steam turbine blades caused by low cycle and strain cycling fatigue, Eng. Fail. Anal. 97 (2019) 579–588. https://doi.org/10.1016/j.engfailanal.2019.01.015. Gao, C. Fei, G. Bai, L. Ding, Reliability-based low-cycle fatigue damage analysis for turbine blade with thermo-structural interaction, Aerosp. Sci. Technol. 49 (2016) 289–300. https://doi.org/10.1016/j.ast.2015.12.017. Gustafsson, J.J. Moverare, S. Johansson, K. Simonsson, M. Hörnqvist, T. Månsson, S. Sjöström, Influence of high temperature hold times on the fatigue crack propagation in Inconel 718, Int. J. Fatigue. 33 (2011) 1461–1469. https://doi.org/10.1016/j.ijfatigue.2011.05.011. M. Seo, I.S. Kim, C.Y. Jo, Low Cycle Fatigue and Fracture Behavior of Nickel-Base Superalloy CM247LC at 760° C, in: Mater. Sci. Forum, Trans Tech Publ, 2004: pp. 561–564. https://doi.org/10.4028/www.scientific.net/MSF.449-452.561. D. Antolovich, S. Liu, R. Baur, Low cycle fatigue behavior of René 80 at elevated temperature, Metall. Trans. A. 12 (1981) 473–481. https://doi.org/10.1007/BF02648545. He, Y. Zhang, W. Qiu, H.-J. Shi, J. Gu, Temperature effect on the low cycle fatigue behavior of a directionally solidified nickel-base superalloy, Mater. Sci. Eng. A. 676 (2016) 246–252. https://doi.org/10.1016/j.msea.2016.08.064. He, Q. Zheng, X. Sun, H. Guan, Z. Hu, K. Tieu, C. Lu, H. Zhu, Effect of temperature and strain amplitude on dislocation structure of M963 superalloy during high-temperature low cycle fatigue, Mater. Trans. 47 (2006) 67–71. https://doi.org/10.2320/matertrans.47.67. Deng, J. Xu, Y. Hu, Z. Huang, L. Jiang, Isothermal and thermomechanical fatigue behavior of Inconel 718 superalloy, Mater. Sci. Eng. A. 742 (2019) 813–819. https://doi.org/10.1016/j.msea.2018.11.052. J. Kashinga, L.G. Zhao, V. V Silberschmidt, F. Farukh, N.C. Barnard, M.T. Whittaker, D. Proprentner, B. Shollock, G. McColvin, Low cycle fatigue of a directionally solidified nickel-based superalloy: Testing, characterisation and modelling, Mater. Sci. Eng. A. 708 (2017) 503–513. https://doi.org/10.1016/j.msea.2017.10.024. Mukherjee, K. Barat, S. Sivaprasad, S. Tarafder, S.K. Kar, Elevated temperature low cycle fatigue behaviour of Haynes 282 and its correlation with microstructure–Effect of ageing conditions, Mater. Sci. Eng. A. 762 (2019) 138073. https://doi.org/10.1016/j.msea.2019.138073. V. Rao, N.C.S. Srinivas, G.V.S. Sastry, V. Singh, Low cycle fatigue, deformation and fracture behaviour of Inconel 617 alloy, Mater. Sci. Eng. A. 765 (2019) 138286. https://doi.org/10.1016/j.msea.2019.138286. Harris, G.L. Erickson, R.E. Schwer, MAR-M247 derivations—CM247 LC DS alloy, CMSX single crystal alloys, properties and performance, Superalloys. 1984 (1984) 221–230. https://doi.org/10.7449/1984/SUPERALLOYS_1984_221_230. -C. Zhao, J.H. Westbrook, Ultrahigh-temperature materials for jet engines, MRS Bull. 28 (2003) 622–630. https://doi.org/10.1557/mrs2003.189. S. Fan, X.G. Yang, D.Q. Shi, S.W. Han, S.L. Li, A quantitative role of rafting on low cycle fatigue behaviour of a directionally solidified Ni-based superalloy through a cross-correlated image processing method, Int. J. Fatigue. 131 (2020) 105305. https://doi.org/10.1016/j.ijfatigue.2019.105305. Radonovich, A.P. Gordon, Methods of extrapolating low cycle fatigue data to high stress amplitudes, 2008. https://doi.org/10.1115/GT2008-50365. R. Daubenspeck, A.P. Gordon, Extrapolation techniques for very low cycle fatigue behavior of a Ni-base superalloy, (2011). https://doi.org/10.1115/1.4003602. Nagarjuna, M. Srinivas, K. Balasubramanian, D.S. Sarmat, Effect of alloying content on high cycle fatigue behaviour of Cu Ti alloys, Int. J. Fatigue. 19 (1997) 51–57. https://doi.org/10.1016/S0142-1123(96)00041-2. Lai, T. Lund, K. Rydén, A. Gabelli, I. Strandell, The fatigue limit of bearing steels–Part I: A pragmatic approach to predict very high cycle fatigue strength, Int. J. Fatigue. 38 (2012) 155–168. https://doi.org/10.1016/j.ijfatigue.2011.09.015. V.U. Praveen, V. Singh, Effect of cold rolling on the Coffin–manson relationship in low-cycle fatigue of superalloy IN718, Metall. Mater. Trans. A. 39 (2008) 79–86. https://doi.org/10.1007/s11661-007-9378-0. Suresh, Fatigue of materials, Cambridge university press, 1998. Liu, Z.J. Zhang, P. Zhang, Z.F. Zhang, Extremely-low-cycle fatigue behaviors of Cu and Cu–Al alloys: Damage mechanisms and life prediction, Acta Mater. 83 (2015) 341–356. https://doi.org/10.1016/j.actamat.2014.10.002. Xue, A unified expression for low cycle fatigue and extremely low cycle fatigue and its implication for monotonic loading, Int. J. Fatigue. 30 (2008) 1691–1698. https://doi.org/10.1016/j.ijfatigue.2008.03.004. Kang, H. Ge, Predicting ductile crack initiation of steel bridge structures due to extremely low-cycle fatigue using local and non-local models, J. Earthq. Eng. 17 (2013) 323–349. https://doi.org/10.1080/13632469.2012.746211. W. Shao, P. Zhang, R. Liu, Z.J. Zhang, J.C. Pang, Z.F. Zhang, Low-cycle and extremely-low-cycle fatigue behaviors of high-Mn austenitic TRIP/TWIP alloys: Property evaluation, damage mechanisms and life prediction, Acta Mater. 103 (2016) 781–795. https://doi.org/10.1016/j.actamat.2015.11.015. Miao, T.M. Pollock, J.W. Jones, Crystallographic fatigue crack initiation in nickel-based superalloy René 88DT at elevated temperature, Acta Mater. 57 (2009) 5964–5974. https://doi.org/10.1016/j.actamat.2009.08.022. G. Wang, J.L. Liu, T. Jin, X.F. Sun, Y.Z. Zhou, Z.Q. Hu, J.H. Do, B.G. Choi, I.S. Kim, C.Y. Jo, Deformation mechanisms of a nickel-based single-crystal superalloy during low-cycle fatigue at different temperatures, Scr. Mater. 99 (2015) 57–60. https://doi.org/10.1016/j.scriptamat.2014.11.026. J. Plumbridge, M.E. Dalski, P.J. Castle, High strain fatigue of a type 316 stainless steel, Fatigue Fract. Eng. Mater. Struct. 3 (1980) 177–188. https://doi.org/10.1111/j.1460-2695.1980.tb01112.x.

LANGUAGE NOTE | Document text in Chinese; abstract also in English. 據史實所可考知，中國古代自殷商時代已傳衍一種存祀的國際關係思想。可以命之為存祀主義。相傳殷商高宗武丁時代已有這種思想。 惟在後世聖賢學者與君后諸侯普遍信持的歷史記載，則多以周武王克商故事為根據。成為歷代傳承的丈事典範。故事內容十分具體而顯明。就是在武王克商之後除了殺掉妲己，並把纣王懸首在白旗上。同時散發鹿台（地名）之財，分發鉅橋（地名）之粟，分给黎民百姓。並派人釋放被囚的箕子（人名）和眾百姓，派人封比干（人名）之墓，表彰商容（人名）的門閭。更封紂的兒子武庚旅父（人名）保存原有的殷商政權。此外更分神農、黃帝、唐堯、虞舜、夏禹等帝王的後人立為封國。因是古代聖賢俱頌稱為王道。 在古代的學術思想名家，先後普遍頌揚武王的存祀主義的王道。有孔子、子思、荀子、以及儒家後學，一致宏揚孔子所説：「興滅國，繼絕世，舉逸民，天下之民歸心焉。」而法家的管子，更是幫助齊桓公實質履行存祀主義，儒家經典盛讚齊桓公的三存亡國，一繼絕世。因是使春秋時代的霸業，有一個存祀主義 王道思想。我人尚可以在《左傳》、《國語》書中發現此一實殘的例子。 存祀主義進入秦漢大一統之世，已在政治運行上消褪。然至明清兩代，更成為封貢體制(Tributary System)中一個政治信念。明清帝君對於朝貢國多有履踐。仍不廢王道。中國最後一次履行存祀主義，是在光緒五年(1879)在日本呑併琉球的交涉中，主張為琉球保存其所據大島，以延績琉球宗廟血祀。此為帝國主義者暗笑中國的迂闊愚昧。然而今世爭殺是尚，弱小民族如何避免征服，逃脱被奴役命運。此是世界人 類共同思考之大問題。According to historical records, since the Shang era, a nationally related ideology regarding the worship of royal ancestors had existed in ancient China. It was believed that such kind of thoughts existed in as early as the Gao-zhong Wu Ding period in the ancient Shang Dynasty. However scholars, kings, queens and the noblemen in later years generally tended to believe in records about inheritance that were based on the story of King Zhou Wu who conquered Shang. This had become the paradigm of historical inheritance. The story was very concrete and its message obvious. After King Wu conquered Shang, apart from killing the Shang King’s concubine Tan Ji and hanging up the head of the infamous King Zhou on a white flag, he also distributed the wealth in Lu-tai and the food in Ju Qiao to civilians; moreover he sent people to release the imprisoned Qi Zi and other civilians; he sent someone to honor the tomb of Bi Gan and decorate the door of Shang Rong; King Zhou s son Wu Gang Lu Fu was allowed to maintain Shang’s political power. In addition, the descendants of Shen Nong, Huang Di, Tang Yao, Yu Shun and Xia Yu were awarded territories. Many ancient scholars lauded such generosity as regal benevolence. Renowned thinkers and philosophers in ancient China had been praising King Wu's regal benevolence ideology. Confucius, Zi Si, Xun Zi and other confucius followers unanimously upheld what Confucius proclaimed, “Assist defeated states to recover, let political regimes of the ousted rulers continue, give glory to hermits of the previous dynasty, then all the people would whole-heartedly render support to the ruling power.” Guan Zi of the Legalistic School helped Qi Wun Gong (Duke of Qi) implement ancestral inheritance. In the Confucius classics, Qi Wun Gong was much acclaimed for rendering help to defeated states three times, and helping to perpetuate ancestral worship of ousted states. Thus we can tell that during the hegemony of the war-tom Spring-autumn era, such royal inheritance thoughts existed. Concrete examples can be found in classics such as “Zou Zhuan" and "Guoyu". The regal benevolence tenet faded out politically in the unified Qin and Han era. Nevertheless, in the Ming and Qing dynasty, it had evolved into a political ideology in the Tributary System The kings of Ming and Qing Dynasty upheld regal benevolence through pledging to protect their protege states. The last ancestral worship tenet was seen in the fifth year of Guang Xu's rule (1879) when Japan had taken Ryukyu Island. The Emperor of the Qing Dynasty insisted that Ryukyu Island should keep Da Dao (Big Island) so as to allow it to maintain its ancestral worship practice and blood-line. The imperialists sneered at China as ignorant and stupid. However, in contemporary time, amidst fighting and killings, how vulnerable tribes could avoid being conquered and enslaved is actually an important issue for all people to ruminate.

The globe is engulfed by one of the most extensive public health crises as COVID-19 has become a leading cause of death worldwide. COVID-19 was first detected in Wuhan, China, in December 2019, causing the severe acute respiratory syndrome. This review discusses issues related to Covid-19 vaccines, such as vaccine development targets, vaccine types, efficacy, limitations and development prospects. Keywords: Covid-19, SARS-CoV-2, vaccine, spike protein. References [1] C. Wang, P. W. Horby, F. G. Hayden, G. F. Gao, A Novel Coronavirus Outbreak of Global Health Concern, The Lancet, Vol. 395, No. 10223, 2020, pp. 470-473, https://doi.org/10.1016/S0140-6736(20)30185-9.[2] T. Singhal, A Review of Coronavirus Disease-2019 (COVID-19), The Indian Journal of Pediatrics, Vol. 87, 2020, pp. 281-286, https://doi.org/10.1007/s12098-020-03263-6.[3] World Health Organization, WHO Coronavirus (COVID-19) Dashboard, https://covid19.who.int/, (accessed on: August 21st, 2021).[4] A. Alimolaie, A Review of Coronavirus Disease-2019 (COVID-19), Biological Science Promotion Vol. 3, No. 6, 2020, pp. 152-157.[5] J. Yang, Y. Zheng, X. Gou, K. Pu, Z. Chen, Q. Guo et al., Prevalence of Comorbidities and Its Effects in Patients Infected with SARS-Cov-2: A Systematic Review and Meta-Analysis, International Journal of Infectious Diseases, Vol. 94, 2020, pp. 91-95, https://doi.org/10.1016/j.ijid.2020.03.017.[6] H. E. Randolph, L. B. Barreiro, Herd Immunity: Understanding COVID-19, Immunity, Vol. 52, No. 5, 2020, pp. 737-741, https://doi.org/10.1016/j.immuni.2020.04.012.[7] F. Jung, V. Krieger, F. Hufert, J. H. Küpper, Herd Immunity or Suppression Strategy to Combat COVID-19, Clinical Hemorheology and Microcirculation, Vol. 75, No. 1, 2020, pp. 13-17, https://doi.org/10.3233/CH-209006.[8] O. Sharma, A. A. Sultan, H. Ding, C. R. Triggle, A Review of the Progress and Challenges of Developing a Vaccine for COVID-19, Frontiers in Immunology, Vol. 11, No. 2413, 2020, pp. 1-17, https://doi.org/10.3389/fimmu.2020.585354.[9] G. D. Sempowski, K. O. Saunders, P. Acharya, K. J. Wiehe, B. F. Haynes, Pandemic preparedness: Developing Vaccines and Therapeutic Antibodies for COVID-19, Cell, Vol. 181, No. 7, 2020, pp. 1458-1463, https://doi.org/10.1016/j.cell.2020.05. 041.[10] A. J. R. Morales, J. A. C. Ospina, E. G. Ocampo, R. V. Peña, Y. H. Rivera, J. P. E. Antezana et al., Clinical, Laboratory and Imaging Features of COVID-19: A Systematic Review and Meta-Analysis. Travel Medicine and Infectious Disease, Vol. 34, 2020, pp. 101-623, https://doi.org/10.1016/j.tmaid.2020.101623.[11] C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu et al., Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China, The Lancet, Vol. 395, No. 10223, 2020, pp. 497-506, https://doi.org/10.1016/S0140-6736(20)30183-5.[12] R. Lu, X. Zhao, J. Li, P. Niu, B. Yang, H. Wu et al., Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding, The Lancet, Vol. 395, No. 10224, 2020, pp. 565-574, https://doi.org/10.1016/S0140-6736(20)30251-8.[13] L. Chen, W. Liu, Q. Zhang, K. Xu, G. Ye, W. Wu et al., RNA Based mNGS Approach Identifies a Novel Human Coronavirus From Two Individual Pneumonia Cases in 2019 Wuhan Outbreak, Emerging Microbes & Infections, Vol. 9, No. 1, 2020, pp. 313-319, https://doi.org/10.1080/22221751.2020.1725399.[14] Y. Chen, Q. Liu, D. Guo, Emerging Coronaviruses: Genome Structure, Replication, and Pathogenesis, Journal of Medical Virology, Vol. 92, No. 4, 2020, pp. 418-423, https://doi.org/10.1002/jmv.25681.[15] D. R. Beniac, A. Andonov, E. Grudeski, T. F. Booth, Architecture of The SARS Coronavirus Prefusion Spike, Nature Structural & Molecular Biology, Vol. 13, No. 8, 2006, pp. 751-752, https://doi.org/10.1038/nsmb1123.[16] B. W. Neuman, G. Kiss, A. H. Kunding, D. Bhella, M. F. Baksh, S. Connelly et al., A Structural Analysis of M Protein in Coronavirus Assembly and Morphology, Journal of Structural Biology, Vol. 174, No. 1, 2011, pp. 11-22, https://doi.org/10.1016/j.jsb.2010.11.021.[17] J. L. N. Torres, M. L. DeDiego, C. V. Báguena, J. M. J. Guardeño, J. A. R. Nava, R. F. Delgado et al., Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Ion Channel Activity Promotes Virus Fitness and Pathogenesis, Plos Pathogens Vol. 10, No. 5, 2014, https://doi.org/10.1371/journal.ppat.1004077.[18] A. R. Fehr, S. Perlman. Coronaviruses: An Overview of Their Replication and Pathogenesis. Coronaviruses, New York, 2015, pp. 1-23.[19] M. Letko, A. Marzi, V. Munster, Functional Assessment of Cell Entry and Receptor Usage for SARS-CoV-2 and Other Lineage B Betacoronaviruses,. Nature Microbiology, Vol. 5, No. 4, 2020, pp. 562-569, https://doi.org/10.1038/s41564-020-0688-y.[20] A. Grifoni, D. Weiskopf, S. I. Ramirez, J. Mateus, J. M. Dan, C. R. Moderbacher et al., Targets of T Cell Responses to SARS-Cov-2 Coronavirus in Humans With COVID-19 Disease and Unexposed Individuals, Cell, Vol. 181, No. 7, 2020, pp. 1489-1501, https://doi.org/10.1016/j.cell.2020.05.015.[21] M. Leslie, T Cells Found in Coronavirus Patients Bode Well for Long-Term Immunity, American Association for the Advancement of Science, Vol. 368, No. 6493, 2020, pp. 809-810, https://doi.org/10.1126/science.368.6493.809.[22] N. L. Bert, A. T. Tan, K. Kunasegaran, C. Y. Tham, M. Hafezi, A. Chia et al., SARS-CoV-2-specific T Cell Immunity in Cases of COVID-19 and SARS, and Uninfected Controls, Nature, Vol. 584, No. 7821, 2020, pp. 457-462, https://doi.org/10.1038/s41586-020-2550-z .[23] E. R. Adams, M. Ainsworth, R. Anand, M. I. Andersson, K. Auckland, J. K. Baillie et al., Antibody Testing for COVID-19: A Report from the National COVID Scientific Advisory Panel, Wellcome Open Research, Vol. 5, 2020, pp. 139-156, https://doi.org/10.12688/wellcomeopenres.15927.1.[24] N. Vabret, G. J. Britton, C. Gruber, S. Hegde, J. Kim, M. Kuksin et al., Immunology of COVID-19: current state of the science, Immunity. Vol. 52, No. 6, 2020, pp. 910-941, https://doi.org/10.1016/j.immuni.2020.05.002[25] W. Liu, A. Fontanet, P. H. Zhang, L. Zhan, Z. T. Xin, L. Baril et al., Two-Year Prospective Study of The Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome, The Journal of Infectious Diseases, Vol. 193, No. 6, 2006, pp. 792-795, https://doi.org/10.1086/500469.[26] E. Callaway, Coronavirus Vaccines Leap Through Safety Trials-But Which Will Work is Anybody's Guess, Nature, Vol. 583, No. 7818, 2020, pp. 669-671, https://doi.org/10.1038/d41586-020-02174-y.[27] Y. Dong, T. Dai, Y. Wei, L. Zhang, M. Zheng, F. Zhou. A Systematic Review of SARS-Cov-2 Vaccine Candidates, Signal Transduction and Targeted Therapy, Vol. 5, No. 1, 2020, pp. 1-14, https://doi.org/10.1038/s41392-020-00352-y. [28] E. P. Regalado, Vaccines for SARS-CoV-2: Lessons from Other Coronavirus Strains. Infectious Diseases and Therapy, Vol. 9, No. 2, 2020, pp. 255-274, https://doi.org/10.1007/s40121-020-00300-x.[29] Y. Cai, J. Zhang, T. Xiao, H. Peng, S. M. Sterling, R. M. Walsh et al., Distinct Conformational States of SARS-CoV-2 Spike Protein, Science, Vol. 369, No. 6511, 2020, pp. 1586-1592, https://doi.org/10.1126/science.abd4251.[30] M. S. Suthar, M. G. Zimmerman, R. C. Kauffman, G. Mantus, S. L. Linderman, W. H. Hudson et al., Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, Cell Reports Medicine, Vol. 1, No. 3, 2020, pp. 100040-100047, https://doi.org/10.1016/j.xcrm.2020.100040.[31] Q. Gao, L. Bao, H. Mao, L. Wang, K. Xu, M. Yang et al., Development of an Inactivated Vaccine Candidate for SARS-CoV-2, Science, Vol. 36, No. 6499, 2020, pp. 77-81, https://doi.org/10.1126/science.abc1932.[32] L. Ni, F. Ye, M. L. Cheng, Y. Feng, Y. Q. Deng, H. Zhao et al., Detection of SARS-CoV-2-specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals, Immunity, Vol. 52, No. 6, 2020, pp. 971-977, https://doi.org/10.1016/j.immuni.2020.04.023.[33] B. D. Quinlan, H. Mou, L. Zhang, Y. Guo, W. He, A. Ojha et al., The SARS-CoV-2 Receptor-binding Domain Elicits a Potent Neutralizing Response Without Antibody-dependent Enhancement, Available at SSRN, Vol. 3575134, 2020, pp. 1-24, http://dx.doi.org/10.2139/ssrn.3575134.[34] D. B. Melo, B. E. N. Payant, W. C. Liu, S. Uhl, D. Hoagland, R. Moller et al., Imbalanced Host Responseto SARS-Cov-2 Drives Development of COVID-19, Cell, Vol. 181, No. 5, 2020, pp. 1036-1045, https://doi.org/10.1016/j.cell.2020.04.026.[35] J. Hadjadj, N. Yatim, L. Barnabei, A. Corneau, J. Boussier, N. Smith et al., Impaired Type I Interferon Activity and Inflammatory Responses in Severe COVID-19 Patients, Science, Vol. 36, No. 6504, 2020, pp. 718-724, https://doi.org/10.1126/science.abc6027.[36] H. Pang, Y. Liu, X. Han, Y. Xu, F. Jiang, D. Wu et al., Protective Humoral Responses to Severe Acute Respiratory Syndrome-associated Coronavirus: Implications for the Design of an Effective Protein-based Vaccine, Journal of General Virology, Vol. 85, No. 10, 2004, pp. 3109-3113, https://doi.org/10.1099/vir.0.80111-0.[37] Y. Li, R. Tenchov, J. Smoot, C. Liu, S. Watkins, Q. Zhou, A Comprehensive Review of The Global Efforts on COVID-19 Vaccine Development, ACS Central Science , Vol. 7, No. 4, 2021, pp. 512-533, https://doi.org/10.1021/acscentsci.1c00120.[38] J. A. Wolff, R. W. Malone, P. Williams, W. Chong, G. Acsadi, A. Jani et al., Direct Gene Transfer Into Mouse Muscle in Vivo, Science, Vol. 247, No. 4949, 1990, pp. 1465-1468,. https://doi.org/10.1126/science.1690918.[39] M. Ingolotti, O. Kawalekar, D. J. Shedlock, K. Muthumani, D. B. Weiner, DNA Vaccines for Targeting Bacterial Infections, Expert Review of Vaccines, Vol. 9, No. 7, 2010, pp. 747-763, https://doi.org/10.1586/erv.10.57.[40] S. Jones, K. Evans, H. M. Johnn, M. Sharpe, J. Oxford, R. L. Williams et al., DNA Vaccination Protects Against an Influenza Challenge in A Double-Blind Randomised Placebo-Controlled Phase 1b Clinical Trial, Vaccine, Vol. 27, No. 18, 2009, pp. 2506-2512, https://doi.org/10.1016/j.vaccine.2009.02.061.[41] J. Kim, INOVIO Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 Clinical Trial for INO-4800, its DNA Medicine to Prevent COVID-19, Cision PR Newswire: News Distribution, Targeting and Monitoring Home, https://www.prnewswire.com/newsreleases/inovio-doses-first-subject-in-phase-2-segment-of-its-innovate-phase-23-clinical-trial-for-ino-4800-its-dna-medicine-to-prevent-covid-19-301187002.html/, 2020, (accessed on: December 7th, 2020).[42] P. Tebas, S. Yang, J. D. Boyer, E. L. Reuschel, A. Patel, A. C. Quick et al., Safety and Immunogenicity of INO-4800 DNA Vaccine Against SARS-Cov-2: A Preliminary Report of an Open-Label, Phase 1 Clinical Trial, EClinical Medicine, Vol. 31, No. 1000689, 2021, https://doi.org/10.1016/j.eclinm.2020.100689.[43] T. Schlake, A. Thess, M. F. Mleczek, K. J. Kallen. Developing mRNA-vaccine Technologies, RNA Biology, Vol. 9, No. 11, 2012, pp. 1319-1330, https://doi.org/10.4161/rna.22269.[44] K. J. Hassett, K. E. Benenato, E. Jacquinet, A. Lee, A. Woods, O. Yuzhakov et al., Optimization of lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines, Molecular Therapy-Nucleic Acids, Vol. 15, 2019, pp. 1-11, https://doi.org/10.1016/j.omtn.2019.01.013.[45] A. Bashirullah, R. L. Cooperstock, H. D. Lipshitz, Spatial and Temporal Control of RNA Stability, Proceedings of the National Academy of Sciences, Vol. 98, No. 13, 2001, pp. 7025-7028. [46] K. Kariko, H. Muramatsu, J. Ludwig, D. Weissman, Generating the Optimal mRNA for Therapy: HPLC Purification Eliminates Immune Activation and Improves Translation of Nucleoside-Modified, Protein-Encoding mRNA, Nucleic Acids Research, Vol. 39, No. 21, 2011, pp. 142-152, https://doi.org/10.1093/nar/gkr695.[47] N. Pardi, M. J. Hogan, M. S. Naradikian, K. Parkhouse, D. W. Cain, L. Jones et al., Nucleoside-Modified mRNA Vaccines Induce Potent T Follicular Helper and Germinal Center B Cell Responses, Journal of Experimental Medicine, Vol. 215, No. 6, 2018, pp. 1571-1588, https://doi.org/10.1084/jem.20171450.[48] L. A. Jackson, E. J. Anderson, N. G. Rouphael, P. C. Roberts, M. Makhene, R. N. Coler et al., An mRNA Vaccine Against SARS-CoV-2-Preliminary Report, New England Journal of Medicine, Vol. 383, No. 20, 2020, pp. 1920-1931, https://doi.org/10.1056/NEJMoa2022483.[49] K. S. Corbett, D. K. Edwards, S. R. Leist, O. M. Abiona, S. B. Barnum, R. A. Gillespie et al., SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness, Nature, Vol. 586, No. 7830, 2020, pp. 567-571, https://doi.org/10.1038/s41586-020-2622-0.[50] K. S. Corbett, B. Flynn, K. E. Foulds, J. R. Francica, S. B. Barnum, A. P. Werner et al., Evaluation of the mRNA-1273 Vaccine Against SARS-CoV-2 in Nonhuman Primates, New England Journal of Medicine, Vol. 383, No. 16, 2020, pp. 1544-1555, https://doi.org/10.1056/NEJMoa2024671.[51] E. E. Walsh, R. Frenck, A. R. Falsey, N. Kitchin, J. Absalon, A. Gurtman et al., RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study, Medrxiv, Vol. 2, 2020, https://doi.org/10.1101/2020.08.17.20176651.[52] M. J. Mulligan, K. E. Lyke, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart et al., Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report, Medrxiv, Vol. 586, 2020, pp. 589-593, https://doi.org/10.1056/NEJMoa2028436.[53] E. J. Anderson, N. G. Rouphael, A. T. Widge, L. A. Jackson, P. C. Roberts, M. Makhene et al., Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults, New England Journal of Medicine, Vol. 383, No. 25, 2020, pp. 2427-2438, https://doi.org/10.1038/s41586-020-2639-4.[54] P. F. McKay, K. Hu, A. K. Blakney, K. Samnuan, J. C. Brown, R. Penn et al., Self-amplifying RNA SARS-CoV-2 Lipid Nanoparticle Vaccine Candidate Induces High Neutralizing Antibody Titers in Mice, Nature Communications, Vol. 11, No. 1, 2020, pp. 1-7, https://doi.org/10.1038/s41467-020-17409-9.[55] J. H. Erasmus, A. P. Khandhar, A. C. Walls, E. A. Hemann, M. A. O’Connor, P. Murapa et al., Single-dose Replicating RNA vaccine Induces Neutralizing Antibodies Against SARS-CoV-2 in Nonhuman Primates, BioRxiv, 2020, https://doi.org/10.1101/2020.05.28.121640.[56] R. D. Alwis, E. S. Gan, S. Chen, Y. S. Leong, H. C. Tan, S. L. Zhang et al., A Single Dose of Self-Transcribing and Replicating RNA-based SARS-CoV-2 Vaccine Produces Protective Adaptive Immunity in Mice, Molecular Therapy, Vol. 29, No. 6, 2021, pp. 1970-1983, https://doi.org/10.1016/j.ymthe.2021.04.001.[57] M. R. Guroff, Replicating and Non-Replicating Viral Vectors for Vaccine Development, Current Opinion in Biotechnology, Vol. 18, No. 6, 2007, pp. 546-556, https://doi.org/10.1016/j.copbio.2007.10.010.[58] K. Benihoud, P. Yeh, M. Perricaudet, Adenovirus Vectors for Gene Delivery, Current Opinion in Biotechnology, Vol. 10, No. 5,1999, pp. 440-447, https://doi.org/10.1016/s0958-1669(99)00007-5.[59] Z. Xiang, G. Gao, A. R. Sandoval, C. J. Cohen, Y. Li, J. M. Bergelson et al., Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to A Transgene Product, Journal of Virology, Vol. 76, No. 6, 2002, pp. 2667-2675, https://doi.org/10.1128/JVI.76.6.2667-2675.2002.[60] F. C. Zhu, X. H. Guan, Y. H. Li, J. Y. Huang, T. Jiang, L. H. Hou et al., Immunogenicity and Safety Of A Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults Aged 18 Years or Older: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial, The Lancet, Vol. 396, No. 10249, 2020, pp. 479-488, https://doi.org/10.1016/S0140-6736(20)31605-6.[61] F. C. Zhu, Y. H. Li, X. H. Guan, L. H. Hou, W. J. Wang, J. X. Li et al., Safety, Tolerability, and Immunogenicity of A Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, First-in-Human Trial, The Lancet. Vol. 395, No. 10240, 2020, pp. 1845-1854.[62] S. Wu, G. Zhong, J. Zhang, L. Shuai, Z. Zhang, Z. Wen, et al. A Single Dose of An Adenovirus-Vectored Vaccine Provides Protection Against SARS-Cov-2 Challenge, Nature Communications Vol. 1, No. 11, 2020, pp. 1-7, https://doi.org/10.1016/s41467-020-17972-1.[63] P. M. Folegatti, K. J. Ewer, P. K. Aley, B. Angus, S. Becker, S. B. Rammerstorfer et al., Safety and Immunogenicity of The Chadox1 Ncov-19 Vaccine Against SARS-Cov-2: A Preliminary Report of A Phase 1/2, Single-Blind, Randomised Controlled Trial, The Lancet, Vol. 396, No. 10249, 2020, pp. 467-478, https://doi.org/10.1016/S0140-6736(20)31604-4.[64] N. V. Doremalen, T. Lambe, A. Spencer, S. B. Rammerstorfer, J. N. Purushotham, J. R. Port et al., ChAdOx1 nCoV-19 Vaccine Prevents SARS-Cov-2 Pneumonia in Rhesus Macaques, Nature, Vol. 586, No. 7830, 2020, pp. 578-582, https://doi.org/10.1016/s41586-020-2608-y.[65] D. Y. Logunov, I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatullin, D. V. Shcheblyakov, A. S. Dzharullaeva et al., Safety and Immunogenicity of an Rad26 And Rad5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine in Two Formulations: Two Open, Non-Randomised Phase 1/2 Studies From Russia, The Lancet, Vol. 396, No. 10255, 2020, pp. 887-897, https://doi.org/10.1016/S0140-6736(20)31866-3.[66] S. Y. Jung, K. W. Kang, E. Y. Lee, D. W. Seo, H. L. Kim, H. Kim et al., Heterologous Prime-Boost Vaccination with Adenoviral Vector and Protein Nanoparticles Induces Both Th1 and Th2 Responses Against Middle East Respiratory Syndrome Coronavirus, Vaccine, Vol. 36, No. 24, 2018, pp. 3468-3476, https://doi.org/10.1016/j.vaccine.2018.04.082.[67] S. Lu, Heterologous Prime-Boost Vaccination. Current Opinion in Immunology, Vol. 21, No. 3, 2009, pp. 346-351, https://doi.org/10.1016/j.coi.2009.05.016.[68] D. Y. Logunov, I. V. Dolzhikova, D. V. Shcheblyakov, A. I. Tukhvatulin, O. V. Zubkova, A. S. Dzharullaeva et al., Safety and Efficacy of an Rad26 and Rad5 Vector-Based Heterologous Prime-Boost COVID-19 Vaccine: an Interim Analysis of A Randomised Controlled Phase 3 Trial in Russia, The Lancet, Vol. 397, No. 10275, 2021, pp. 671-681, https://doi.org/10.1016/S0140-6736(21)00234-8.[69] T. Ura, K. Okuda, M. Shimada. Developments in Viral Vector-Based Vaccines, Vaccines, Vol. 2, No. 3, 2014, pp. 624-641, https://doi.org/10.3390/vaccines2030624.[70] B. E. Bache, M. P. Grobusch, S. T. Agnandji. Safety, Immunogenicity and Risk-Benefit Analysis of Rvsv-ΔG-ZEBOV-GP (V920) Ebola Vaccine in Phase I-III Clinical Trials Across Regions. Future Microbiology, Vol. 15, No. 2, 2020, pp. 85-106, https://doi.org/10.2217/fmb-2019-0237.[71] Ebola Vaccines, NIH: National Institute of Allergy and Infectious Diseases Logo, 2020, https://www.niaid.nih.gov/diseases-conditions/ebola-vaccines/, (accessed on: January 9th, 2020).[72] F. Krammer, SARS-CoV-2 Vaccines in Development, Nature, Vol. 586, No. 7830, 2020, pp. 516-527, https://doi.org/10.1038/s41586-020-2798-3.[73] Y. Zhang, G. Zeng, H. Pan, C. Li, Y. Hu, K. Chu et al., Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18-59 Years: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial, The Lancet Infectious Diseases, Vol. 21, No. 2, 2021, pp. 181-192, https://doi.org/10.1016/S1473-3099(20)30843-4.[74] Sinovac Announces Phase III Results of Its COVID-19 Vaccine, Sinovac, 2021. https://www.businessswwire.com/news/home/20210205005496/en/Sinovac-Announces-Phase-III-Results-of-Its-COVID-19-Vaccine/, 2021, (accessed on: February 5th,2021).[75] Sinovac Receives Conditional Marketing Authorization in China for its COVID-19 Vaccine. Sinovac, https://www.businessswwire.com/news/ home/20210208005305/en/Sinovac-Receives-Conditional-Marketing-Authorization-in-China-for-its-COVID-19-Vaccin/, 2021, (accessed on: February 8th, 2021).[76] L. M. Rossen, A. M. Branum, F. B. Ahmad, P. Sutton, R. N. Anderson, Excess Deaths Associated with COVID-19, by Age and Race and Ethnicity-United States, January 26-October 3, 2020, Morbidity and Mortality Weekly Report, Vol. 69, No. 42, 2020, pp. 1522-1527.[77] China Grants Conditional Market Approval for Sinopharm CNBG’s COVID-19 Vaccine. Sinopharm, http://www.sinopharm.com/en/s/1395-4173-38862.html/, 2021, (accessed on: January 2nd, 2021).[78] V. A. Fulginiti, J. J. Eller, A. W. Downie, C. H. Kempe, Altered Reactivity to Measles Virus: Atypical Measles in Children Previously Immunized with Inactivated Measles Virus Vaccines, Jama, Vol. 202, No. 12, 1967, pp. 1075-1080, https://doi.org/10.1001/jama.1967.03130250057008.[79] H. W. Kim, J. G. Canchola, C. D. Brandt, G. Pyles, R. M. Chanock, K. Jensen et al., Respiratory Syncytial Virus Disease in Infants Despite Prior Administration of Antigenic Inactivated Vaccine. American Journal of Epidemiology, Vol. 89, No. 4, 1969, pp. 422-434, https://doi.org/10.1093/oxfordjournals.aje.a120955.[80] Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials, Novavax 2021, https://www.prnewswire.com/news-releases/novavax-confirms-high-levels-of-efficacy-against-original-and-variant-covid-19-strains-in-united-kingdom-and-south-africa-trials-301246019.html/, (accessed on: March 11th, 2021).[81] Our Vaccine, Covaxx, 2020, https://www.gavi.org/covax-vaccine-roll-out/, (accessed on: August 14th, 2021).[82] M. O. Mohsen, G. Augusto, M. F. Bachmann, The 3Ds in Virus‐like Particle Based‐vaccines: Design, Delivery and Dynamics, Immunological Reviews Vol. 296, No. 1, 2020, pp. 155-168, https://doi.org/10.1111/imr.12863.

Сплавы на основе олова и сурьмы, в том числе SnSb и некоторые другие соединения типа AIVBV, применяются для изготовления анодов Li+- и Na+-ионных батарей. Использование ногокомпонентных твердых растворов позволяет варьировать свойства материала и улучшать технические характеристики анодов. В литературе очень мало информации о твердофазной растворимости в системе Sn–As–Sb, фазовая диаграмма этой системы не изучена.Цель работы заключалась в исследовании политермических сечений SnAs–Sb и SnAs–SnSb с помощью методов рентгенофазового анализа (РФА) и дифференциального термического анализа (ДТА) и построении схемы фазовых равновесий в системе Sn–As–Sb в области концентраций олова менее 50 мол.%. Сплавы политермических разрезов SnAs–Sb и SnAs–SnSb получали из предварительно синтезированных бинарных соединений, подвергали гомогенизирующему отжигу и исследовали с помощью методов дифференциального термического анализа (ДТА) и рентгенофазового анализа (РФА) порошкообразных образцов. Результаты РФА показали, что все исследованные сплавы представляют собой гетерофазную смесь твердых растворов (SnAs), (SnSb) и a¢, где a¢ – твердый раствор олова в фазе As1–xSbx. Протяженность твердых растворов на основе бинарных соединений при комнатной температуре менее 10 мол.%. Для нескольких сплавов двух разрезов методомДТА установлена одинаковая температура начала первого эндотермического эффекта (393±2 oС), которая отвечает протеканию перитектического процесса с участием указанных выше фаз: L+ a¢ ↔ (SnAs) + (SnSb). Методом ДТА с учетом данных РФА построены Т–х диаграммы политермических разрезов SnAs–Sb и SnAs–SnSb. Установлены координаты нонвариантного перитектического равновесия L+ a¢ ↔ (SnAs) + (SnSb); предложена схема фазовых равновесий в системе Sn–As–Sb в области концентраций олова менее 50 мол.%. Для построения полной схемы фазовых равновесий в тройной системе необходимо дальнейшее исследование разрезов SnAs–Sn4Sb3 и Sn4As3–Sn4Sb3 ЛИТЕРАТУРА Hu Y., Lu Y. 2019 Nobel Pprize for the Li-ion batteries and new opportunities and challenges in Na-ion batteries. ACS Energy Letters. 2019;4(11): 2689–2690. DOI: https://doi.org/10.1021/acsenergylett.9b02190 Song K., Liu C., Mi L., Chou S., Chen W., Shen C. Recent progress on the alloy-based anode for sodiumion batteries and potassium-ion batteries. Small. 2019;334: 1903194. DOI: https://doi.org/10.1002/smll.201903194 Kulova T. L., Skundin A. M.. From lithium-ion to sodium-ion battery. Russian Chemical Bulletin. 2017;66(8): 1329–1335. DOI: https://doi.org/10.1002/smll.20190319410.1007/s11172-017-1896-3 Jing W. T., Yang C. C., Jiang Q. Recent progress on metallic Sn- and Sb-based anodes for sodium-ion batteries. Journal of Materials Chemistry A. 2020; Advance Article. DOI: https://doi.org/10.1039/C9TA11782B Kamali A. R., Fray D. J. Tin-based materials as advanced anode materials for lithium ion batteries: a review. Reviews on Advanced Material Science. 2011;27: 14–24. Available at: http://194.226.210.10/e-journals/RAMS/no12711/kamali.pdf Wachtler M., Winter M., Besenhard J. O. Anodic materials for rechargeable Li-batteries. Journal of Power Sources. 2002;105: 151–160. DOI: https://doi.org/10.1016/S0378-7753(01)00934-X Wachtler M., Besenhard J.O., Winter M. Tin and tin-based intermetallics as new anode materials for lithium-ion cells. Journal of Power Sources. 2001;94: 189–193. DOI: https://doi.org/10.1016/S0378-7753(00)00585-1 Xie H., Tan X., Luber E.J., Olsen B.C., Kalisvaart W. P., Jungjohann K. L., Mitlin D., Buriak J. M. b-SnSb for sodium ion battery anodes: phase transformations responsible for Eenhanced cycling stability revealed by in situ TEM. ACS Energy Letters. 2018;3(7): 1670–1676. DOI: https://doi.org/10.1021/acsenergylett.8b00762. Li H., Wang Q., Shi L., Chen L., Huang X. Nanosized SnSb Alloy Pinning on hard non-graphitic carbon spherules as anode materials for a Li-ion battery. Chemistry of Materials. 2002;14(1): 103–108. DOI: https://doi.org/10.1021/cm010195p Huang B., Pan Z., Su X., An L. Tin-based materials as versatile anodes for alkali (earth)-ion batteries. Journal of Power Sources. 2018;395: 41-59. DOI: https://doi.org/10.1016/j.jpowsour.2018.05.063. Zhang W., Pang W., Sencadas V., Guo Z. Understanding high-Eenergy-density Sn4P3 Aanodes for potassium-ion batteries. Joule. 2018;2(8): 1534–1547. DOI: https://doi.org/10.1016/j.joule.2018.04022 Jung S.C., Choi J., Han Y. The origin of excellent rate and cycle performance of Sn4P3 binary electrodes for sodium-ion batteries. Journal of Materials Chemistry A. 2018;6(4): 1772–1779. DOI: https://doi.org/10.1039/C7TA07310K Domi Y., Usui H., Nakabayashi E., Yamamoto T., Nohira T., Hiroki Sakaguchi H. Potassiation and depotassioation Pproperties of Sn4P3 electrode in an ionic-liquid electrolyte. Electrochemistry. 2019;87(6): 333–335. DOI: https://doi.org/10.5796/electrochemistry.19-00052 Saddique J., Zhang X., Wu T., Su H., Liu S., Zhang D., Zhang Y., Yu H. Sn4P3-induced crystalline/amorphous composite structures for enhanced sodium-ion battery anodes. Journal of Materials Science & Technology. 2019. In Press. DOI: https://doi.org/10.1016/j.jmst.2019.05.032 Zhang J., Wang W., Li B. Effect of particle size on the sodium storage performance of Sn4P3. Journal of Alloys and Compounds. 2019;771: 204–208. DOI: https://doi.org/10.1016/j.jallcom.2018.08.271 Lan D., Li Q. Sn4P3/SbSn nanocomposites for anode application in sodium-ion batteries. ChemElec troChem. 2018;5(17): 2383–2386. DOI: https://doi.org/10.1002/celc.201800639 Lee K. Synthesis and characterization of tetrel pnictides and compounds in the lithium-tetrel-arsenic system. Dissertation. University of California, Davis; 2016. 136 p. Available at: https://search.proquest.com/openview/6c5577b9817fa2c2864fdeda33e2acfb/1?pq-origsite=gscholar&cbl=18750&diss=y Usui H., Domi Y., Yamagami R., Fujiwara K., Nishida H., Sakaguchi H. Sodiation–desodiation reactions of various binary phosphides as novel anode materials of Na-ion battery. ACS Applied Energy Materials. 2018;1(2): 306–311. DOI: https://doi.org/10.1021/acsaem.7b00241 Liu S., Zhang H., Xu L., Ma L., Chen X. Solvothermal preparation of tin phosphide as a longlife anode for advanced lithium and sodium ion batteries. Journal of Power Sources. 2016;304: 346– 353. DOI: https://doi.org/10.1016/j.jpowsour.2015.11.056 Liu J., Wang S., Kravchyk K., Ibáñez M., Krumeich F., Widmer R., Nasiou D., Meyns M., Llorca J., Arbiol J., Kovalenko M.V., Cabot A. SnP nanocrystals as anode materials for Na-ion batteries. Journal of Materials Chemistry A. 2018;6(23): 10958–10966. DOI: https://doi.org/10.1039/C8TA01492B Liu C., Yang X., Liu J., Ye X. Theoretical Prediction of Two-Dimensional SnP3 as a Promising Anode Material for Na-Ion Batteries. ACS Applied Energy Materials. 2018;1(8): 3850-3859. DOI: https://doi.org/10.1021/acsaem.8b00621 Saddique J, Zhang X., Wu T, Wang X., Cheng X., Su H., Liu S., Zhang L., Li G., Zhang Y., Yu H. Enhanced Silicon Diphosphide-Carbon Composite Anode for Long-Cycle, High-effi cient sodium ion batteries. ACS Applied Energy Materials. 2019;2(3): 2223–2229. DOI: https://doi.org/10.1021/acsaem.8b02242 Schmetterer С., Polt J., Flandorfer H. The phase equilibria in the Sb-Sn system. Part I: Literature review. Journal of Alloys and Compounds. 2017;728: 497–505. DOI: https://doi.org/10.1016/j.jallcom. 2017.08.215 Schmetterer С., Polt J., Flandorfer H. The phase equilibria in the Sb-Sn system. Part II: Experimental results. Journal of Alloys and Compounds. 2018;743: 523–536. DOI: https://doi.org/10.1016/j.jallcom.2017.11.367 Kovnir K.A., Kolen’ko Yu.V., Baranov A.I., Neira I.S., Sobolev AV., Yoshimura M., Presniakov I.A., Shevelkov A.V. A Sn4As3 revisited: Solvothermal synthesis and crystal and electronic structure. Journal of Solid State Chemistry. 2009;182(3): 630–639. DOI: https://doi.org/10.1016/j.jssc.2008.12.007 Kovnir K.A., Kolen’ko Yu.V., Ray S., Li J., Watanabe T., Itoh M., Yoshimura M., Shevelkov A.V. A facile high-yield solvothermal route to tin phosphide Sn4P3. Journal of Solid State Chemistry. 2006;179(12): 3756–3762. DOI: https://doi.org/10.1016/j.jssc.2006.08.012 Семенова Г. В., Гончаров Е. Г. Твердые растворы в тройных системах с участием элементов пятой группы. М.: Моск. физ.-техн. ин-т; 2000. 160 с. 28. Woo K. E., Dolyniuk J., Kovnir K. Superseding van der Waals with electrostatic interactions: intercalation of Cs into the interlayer space of SiAs2. Inorganic Chemistry.2019;58(8): 4997–5005. DOI: https://doi.org/10.1021/acs.inorgchem.9b00017 Woo K. E., Dolyniuk J., Kovnir K. Supersedingvan der Waals with electrostatic interactions: intercalation of Cs into the interlayer space of SiAs2. Inorganic Chemistry.2019;58(8): 4997–5005. DOI: https://doi.org/10.1021/acs.inorgchem.9b00017 Семенова Г. В., Кононова Е. Ю., Сушкова Т. П. Политермический разрез Sn4P3–Sn4As3. Журнал неорганической химии. 2013;58: 1242–1245. DOI: https://doi.org/10.7868/S0044457X13090201 Kononova E. Yu., Semenova G. V., Sinyova S. I., Sushkova T. P. Phase equilibria in the Sn–As–Ge and Sn–As–P systems. Journal of Thermal Analysis and Calorimetry. 2014;117(3): 1171–1177. DOI: https://doi.org/10.1007/s10973-014-3883-3 Сушкова Т. П., Семенова Г. В., Наумов А. В., Проскурина Е. Ю. Твердые растворы в системе Sn-As–P. Вестник ВГУ. Серия: Химия. Биология. Фармация. 2017;3: 30–36. Режим доступа: http://www.vestnik.vsu.ru/pdf/chembio/2017/03/2017-03-05.pdf Семенова Г. В., Сушкова Т. П., Зинченко Е. Н., Якунин С. В. Растворимость фосфора в моноарсениде олова. Конденсированные среды и межфазные границы. 2018;20(4): 644–649. DOI: https://doi.org/10.17308/kcmf.2018.20/639 Okamoto H., Subramanian P.R., Kacprzak L., Massalski T. B. Binary Alloy Phase Diagrams, Second Edition. Ohio: ASM International, Materials Park; 1990. 810 p. Allen W. P., Perepezko J. H. Solidifi cation of undercooled Sn-Sb peritectic alloys: Part 1. Microstructural evolution. Metallurgical Transactions A. 1991;22: 753–764. DOI: https://doi.org/10.1007/BF02670298 Gokcen N.A. The As–Sn (Tin-Arsenic) system. Bulletin of alloy phase diagrams. 1990;11(3): 271–278. DOI: https://doi.org/10.1007/bf03029298 Эмсли Дж. Элементы. М.: Мир; 1993. 256 c.